WO2022014414A1 - 光学活性な化合物の製造方法 - Google Patents
光学活性な化合物の製造方法 Download PDFInfo
- Publication number
- WO2022014414A1 WO2022014414A1 PCT/JP2021/025489 JP2021025489W WO2022014414A1 WO 2022014414 A1 WO2022014414 A1 WO 2022014414A1 JP 2021025489 W JP2021025489 W JP 2021025489W WO 2022014414 A1 WO2022014414 A1 WO 2022014414A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- optically active
- formula
- trimethyl
- cobalt
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 140
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 44
- 150000004700 cobalt complex Chemical class 0.000 claims abstract description 40
- 239000001257 hydrogen Substances 0.000 claims abstract description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 40
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 35
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 33
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 9
- -1 hydride boron alkali metal salt Chemical class 0.000 claims description 159
- 239000002904 solvent Substances 0.000 claims description 128
- 239000010941 cobalt Substances 0.000 claims description 107
- 229910017052 cobalt Inorganic materials 0.000 claims description 107
- KYWYAWFSWFSPAY-UHFFFAOYSA-N 1,1,3-trimethyl-2,3-dihydroinden-4-amine Chemical compound C1=CC(N)=C2C(C)CC(C)(C)C2=C1 KYWYAWFSWFSPAY-UHFFFAOYSA-N 0.000 claims description 102
- 239000002253 acid Substances 0.000 claims description 79
- 238000006243 chemical reaction Methods 0.000 claims description 77
- 125000001424 substituent group Chemical group 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 239000003638 chemical reducing agent Substances 0.000 claims description 25
- 150000004678 hydrides Chemical group 0.000 claims description 23
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 22
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 20
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 20
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 20
- 239000011975 tartaric acid Substances 0.000 claims description 20
- 235000002906 tartaric acid Nutrition 0.000 claims description 20
- 125000005843 halogen group Chemical group 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 238000002425 crystallisation Methods 0.000 claims description 10
- 230000008025 crystallization Effects 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 10
- 229910052783 alkali metal Inorganic materials 0.000 claims description 9
- 238000010494 dissociation reaction Methods 0.000 claims description 9
- 125000005270 trialkylamine group Chemical group 0.000 claims description 9
- 230000005593 dissociations Effects 0.000 claims description 8
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 5
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 5
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 3
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 3
- 150000001868 cobalt Chemical class 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 claims description 2
- RXTJLDXSGNEJIT-UHFFFAOYSA-N 2,3-dihydro-1h-inden-4-amine Chemical compound NC1=CC=CC2=C1CCC2 RXTJLDXSGNEJIT-UHFFFAOYSA-N 0.000 claims description 2
- 230000029936 alkylation Effects 0.000 claims description 2
- 238000005804 alkylation reaction Methods 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 23
- DICCKTLYSLKYNN-UHFFFAOYSA-N 1-(2,2,4-trimethyl-3,4-dihydroquinolin-1-yl)ethanone Chemical compound C1=CC=C2C(C)CC(C)(C)N(C(C)=O)C2=C1 DICCKTLYSLKYNN-UHFFFAOYSA-N 0.000 abstract description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 142
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 116
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 114
- 239000000203 mixture Substances 0.000 description 113
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 70
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 62
- 125000000950 dibromo group Chemical group Br* 0.000 description 55
- 230000003287 optical effect Effects 0.000 description 55
- 239000000243 solution Substances 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 42
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- 239000011541 reaction mixture Substances 0.000 description 36
- 239000013078 crystal Substances 0.000 description 35
- 238000002156 mixing Methods 0.000 description 35
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 31
- 125000003963 dichloro group Chemical group Cl* 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 29
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 28
- 239000007864 aqueous solution Substances 0.000 description 28
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 27
- 229910052757 nitrogen Inorganic materials 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 27
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 27
- 150000003839 salts Chemical class 0.000 description 27
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 22
- 238000007112 amidation reaction Methods 0.000 description 20
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 20
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 20
- 239000003960 organic solvent Substances 0.000 description 19
- 229960001367 tartaric acid Drugs 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 18
- 239000002585 base Substances 0.000 description 18
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 17
- 239000008096 xylene Substances 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 15
- 239000004210 ether based solvent Substances 0.000 description 15
- 150000002431 hydrogen Chemical group 0.000 description 15
- KYWYAWFSWFSPAY-MRVPVSSYSA-N (3r)-1,1,3-trimethyl-2,3-dihydroinden-4-amine Chemical compound C1=CC(N)=C2[C@H](C)CC(C)(C)C2=C1 KYWYAWFSWFSPAY-MRVPVSSYSA-N 0.000 description 14
- 238000004128 high performance liquid chromatography Methods 0.000 description 14
- 238000006467 substitution reaction Methods 0.000 description 14
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 11
- 238000004811 liquid chromatography Methods 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 10
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 150000007513 acids Chemical class 0.000 description 9
- 125000001153 fluoro group Chemical group F* 0.000 description 9
- 235000011007 phosphoric acid Nutrition 0.000 description 9
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 125000004104 aryloxy group Chemical group 0.000 description 8
- 229960001270 d- tartaric acid Drugs 0.000 description 8
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 8
- 239000003759 ester based solvent Substances 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- 239000002841 Lewis acid Substances 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- BZRRQSJJPUGBAA-UHFFFAOYSA-L cobalt(ii) bromide Chemical compound Br[Co]Br BZRRQSJJPUGBAA-UHFFFAOYSA-L 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 150000007517 lewis acids Chemical class 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 150000002825 nitriles Chemical class 0.000 description 6
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229940095064 tartrate Drugs 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 238000006317 isomerization reaction Methods 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000012453 solvate Substances 0.000 description 5
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 4
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- MZGPCLIDFPCPTI-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole-4-carbonyl chloride Chemical compound CN1C=C(C(Cl)=O)C(C(F)F)=N1 MZGPCLIDFPCPTI-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000005456 alcohol based solvent Substances 0.000 description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 4
- 150000008041 alkali metal carbonates Chemical class 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 description 3
- RLOHOBNEYHBZID-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid Chemical compound CN1C=C(C(O)=O)C(C(F)F)=N1 RLOHOBNEYHBZID-UHFFFAOYSA-N 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 239000002879 Lewis base Substances 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 229940092714 benzenesulfonic acid Drugs 0.000 description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 3
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 3
- 150000007527 lewis bases Chemical class 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 3
- 150000003016 phosphoric acids Chemical class 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 3
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- JXHZRQHZVYDRGX-UHFFFAOYSA-M sodium;hydrogen sulfate;hydrate Chemical compound [OH-].[Na+].OS(O)(=O)=O JXHZRQHZVYDRGX-UHFFFAOYSA-M 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- LWNGJAHMBMVCJR-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenoxy)boronic acid Chemical compound OB(O)OC1=C(F)C(F)=C(F)C(F)=C1F LWNGJAHMBMVCJR-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 2
- KSNRDYQOHXQKAB-UHFFFAOYSA-N 2,2,4-trimethyl-3,4-dihydro-1h-quinoline Chemical class C1=CC=C2C(C)CC(C)(C)NC2=C1 KSNRDYQOHXQKAB-UHFFFAOYSA-N 0.000 description 2
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 2
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 2
- CAWOFIUGLCYJRX-UHFFFAOYSA-N 5,6,7-trimethyl-2,3-dihydro-1H-inden-4-amine Chemical compound NC1=C2CCCC2=C(C(=C1C)C)C CAWOFIUGLCYJRX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 229940117389 dichlorobenzene Drugs 0.000 description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 230000002554 disease preventive effect Effects 0.000 description 2
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 2
- UARGAUQGVANXCB-UHFFFAOYSA-N ethanol;zirconium Chemical compound [Zr].CCO.CCO.CCO.CCO UARGAUQGVANXCB-UHFFFAOYSA-N 0.000 description 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 229910001510 metal chloride Inorganic materials 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- HKJYVRJHDIPMQB-UHFFFAOYSA-N propan-1-olate;titanium(4+) Chemical compound CCCO[Ti](OCCC)(OCCC)OCCC HKJYVRJHDIPMQB-UHFFFAOYSA-N 0.000 description 2
- XPGAWFIWCWKDDL-UHFFFAOYSA-N propan-1-olate;zirconium(4+) Chemical compound [Zr+4].CCC[O-].CCC[O-].CCC[O-].CCC[O-] XPGAWFIWCWKDDL-UHFFFAOYSA-N 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- OBROYCQXICMORW-UHFFFAOYSA-N tripropoxyalumane Chemical compound [Al+3].CCC[O-].CCC[O-].CCC[O-] OBROYCQXICMORW-UHFFFAOYSA-N 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 2
- VASOMTXTRMYSKD-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl)boronic acid Chemical compound OB(O)C1=C(F)C(F)=C(F)C(F)=C1F VASOMTXTRMYSKD-UHFFFAOYSA-N 0.000 description 1
- UIQVGMBTAXORQL-YGEZSCCGSA-N (2S,3S)-2,3-dihydroxybutanedioic acid methanol Chemical compound CO.C(=O)(O)[C@@H](O)[C@H](O)C(=O)O UIQVGMBTAXORQL-YGEZSCCGSA-N 0.000 description 1
- KYWYAWFSWFSPAY-QMMMGPOBSA-N (3S)-1,1,3-trimethyl-2,3-dihydroinden-4-amine Chemical compound C[C@H]1CC(C)(C)C2=CC=CC(N)=C12 KYWYAWFSWFSPAY-QMMMGPOBSA-N 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- 0 *C(C=C(*)c1cc(*)c2[*+])(N(C(*)=C)c1c2N)I Chemical compound *C(C=C(*)c1cc(*)c2[*+])(N(C(*)=C)c1c2N)I 0.000 description 1
- PZQMTQMCJDALRA-UHFFFAOYSA-N 1,1-dimethyl-3-propyl-2,3-dihydroinden-4-amine Chemical compound CC1(CC(C=2C(=CC=CC1=2)N)CCC)C PZQMTQMCJDALRA-UHFFFAOYSA-N 0.000 description 1
- SBZHMJPCGSXTKR-UHFFFAOYSA-N 1-(2,2,4,7-tetramethyl-3,4-dihydroquinolin-1-yl)ethanone Chemical compound CC1CC(C)(C)N(C(C)=O)c2cc(C)ccc12 SBZHMJPCGSXTKR-UHFFFAOYSA-N 0.000 description 1
- MOHGKCPAQLSAOF-UHFFFAOYSA-N 1-(2,2-dimethyl-4-propyl-3,4-dihydroquinolin-1-yl)ethanone Chemical compound CCCC1CC(C)(C)N(C(C)=O)C2=CC=CC=C12 MOHGKCPAQLSAOF-UHFFFAOYSA-N 0.000 description 1
- BHJHVXBWRQTCRB-UHFFFAOYSA-N 1-(6-fluoro-2,2,4-trimethyl-3,4-dihydroquinolin-1-yl)ethanone Chemical compound CC1CC(C)(C)N(C(C)=O)c2ccc(F)cc12 BHJHVXBWRQTCRB-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 1
- GBSQTQRZHMQHGH-UHFFFAOYSA-N 2-pyridin-2-yl-4,5-dihydro-1,3-oxazole Chemical class O1CCN=C1C1=CC=CC=N1 GBSQTQRZHMQHGH-UHFFFAOYSA-N 0.000 description 1
- VSBGXNYEGBRDOB-SECBINFHSA-N 3-(difluoromethyl)-1-methyl-5-[(3R)-1,1,3-trimethyl-2,3-dihydroinden-4-yl]pyrazole-4-carboxamide Chemical compound FC(C1=NN(C(=C1C(=O)N)C1=C2[C@@H](CC(C2=CC=C1)(C)C)C)C)F VSBGXNYEGBRDOB-SECBINFHSA-N 0.000 description 1
- YPELRZNBAVKMGP-UHFFFAOYSA-N 3-(difluoromethyl)-5-methyl-1H-pyrazole-4-carboxamide Chemical compound CC1=C(C(=NN1)C(F)F)C(=O)N YPELRZNBAVKMGP-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- STSFMIVUCFOKIQ-UHFFFAOYSA-N 3-ethyl-1,1-dimethyl-2,3-dihydroinden-4-amine Chemical compound CCC1CC(C)(C)C2=CC=CC(N)=C12 STSFMIVUCFOKIQ-UHFFFAOYSA-N 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- XQABVLBGNWBWIV-UHFFFAOYSA-N 4-methoxypyridine Chemical compound COC1=CC=NC=C1 XQABVLBGNWBWIV-UHFFFAOYSA-N 0.000 description 1
- USXBDIZEJAVICB-UHFFFAOYSA-N 7-fluoro-1,1,3-trimethyl-2,3-dihydroinden-4-amine Chemical compound NC1=CC=C(F)C2=C1C(C)CC2(C)C USXBDIZEJAVICB-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- XHRHWPTXIWPXTP-UHFFFAOYSA-N C(C)(=O)NC1=C2C(CC(C2=CC=C1)(C)C)C Chemical compound C(C)(=O)NC1=C2C(CC(C2=CC=C1)(C)C)C XHRHWPTXIWPXTP-UHFFFAOYSA-N 0.000 description 1
- KFORTUURRPKHRY-UHFFFAOYSA-N CC1CC(C)(C)c2c1c(NC(C)=O)ccc2F Chemical compound CC1CC(C)(C)c2c1c(NC(C)=O)ccc2F KFORTUURRPKHRY-UHFFFAOYSA-N 0.000 description 1
- LOWPIOLRSXPTSO-UHFFFAOYSA-N CCCC1CC(C)(C)C2=CC=CC(NC(C)=O)=C12 Chemical compound CCCC1CC(C)(C)C2=CC=CC(NC(C)=O)=C12 LOWPIOLRSXPTSO-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QLZHNIAADXEJJP-UHFFFAOYSA-N Phenylphosphonic acid Chemical compound OP(O)(=O)C1=CC=CC=C1 QLZHNIAADXEJJP-UHFFFAOYSA-N 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- WLYPBMBWKYALCG-UHFFFAOYSA-N [2,4-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1C(F)(F)F WLYPBMBWKYALCG-UHFFFAOYSA-N 0.000 description 1
- FYJKEHKQUPSJDH-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;potassium Chemical compound [K].C[Si](C)(C)N[Si](C)(C)C FYJKEHKQUPSJDH-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-N bromoacetic acid Chemical compound OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006251 butylcarbonyl group Chemical group 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 229910001429 cobalt ion Inorganic materials 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- GUTLYIVDDKVIGB-BJUDXGSMSA-N cobalt-58 Chemical compound [58Co] GUTLYIVDDKVIGB-BJUDXGSMSA-N 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- OCDXZFSOHJRGIL-UHFFFAOYSA-N cyclohexyloxycyclohexane Chemical compound C1CCCCC1OC1CCCCC1 OCDXZFSOHJRGIL-UHFFFAOYSA-N 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000006612 decyloxy group Chemical group 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VJDVOZLYDLHLSM-UHFFFAOYSA-N diethylazanide;titanium(4+) Chemical compound [Ti+4].CC[N-]CC.CC[N-]CC.CC[N-]CC.CC[N-]CC VJDVOZLYDLHLSM-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-O dimethyl(phenyl)azanium Chemical compound C[NH+](C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-O 0.000 description 1
- BYXDUORQHWFHKS-UHFFFAOYSA-L dimethylazanide;titanium(4+);dichloride Chemical compound [Cl-].[Cl-].CN(C)[Ti+2]N(C)C BYXDUORQHWFHKS-UHFFFAOYSA-L 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical class OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- MRQQMVMIANXDKC-UHFFFAOYSA-N ethyl 3-(difluoromethyl)-1-methylpyrazole-4-carboxylate Chemical compound CCOC(=O)C1=CN(C)N=C1C(F)F MRQQMVMIANXDKC-UHFFFAOYSA-N 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- BLHLJVCOVBYQQS-UHFFFAOYSA-N ethyllithium Chemical compound [Li]CC BLHLJVCOVBYQQS-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000006419 fluorocyclopropyl group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XBFMJHQFVWWFLA-UHFFFAOYSA-N hexane;pentane Chemical compound CCCCC.CCCCCC XBFMJHQFVWWFLA-UHFFFAOYSA-N 0.000 description 1
- YTCIYOXHHQLDEI-SNVBAGLBSA-N inpyrfluxam Chemical compound C([C@H](C=12)C)C(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)F YTCIYOXHHQLDEI-SNVBAGLBSA-N 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- HPCCWDVOHHFCKM-UHFFFAOYSA-M lithium;hydrogen sulfate Chemical compound [Li+].OS([O-])(=O)=O HPCCWDVOHHFCKM-UHFFFAOYSA-M 0.000 description 1
- XBEREOHJDYAKDA-UHFFFAOYSA-N lithium;propane Chemical compound [Li+].CC[CH2-] XBEREOHJDYAKDA-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- GHDIHPNJQVDFBL-UHFFFAOYSA-N methoxycyclohexane Chemical compound COC1CCCCC1 GHDIHPNJQVDFBL-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- YZERDTREOUSUHF-UHFFFAOYSA-N pentafluorobenzoic acid Chemical compound OC(=O)C1=C(F)C(F)=C(F)C(F)=C1F YZERDTREOUSUHF-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000004675 pentylcarbonyl group Chemical group C(CCCC)C(=O)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004673 propylcarbonyl group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- MNWRORMXBIWXCI-UHFFFAOYSA-N tetrakis(dimethylamido)titanium Chemical compound CN(C)[Ti](N(C)C)(N(C)C)N(C)C MNWRORMXBIWXCI-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 description 1
- MCULRUJILOGHCJ-UHFFFAOYSA-N triisobutylaluminium Chemical compound CC(C)C[Al](CC(C)C)CC(C)C MCULRUJILOGHCJ-UHFFFAOYSA-N 0.000 description 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/06—Cobalt compounds
- C07F15/065—Cobalt compounds without a metal-carbon linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/86—Separation
- C07C209/88—Separation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
- C07C211/60—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton containing a ring other than a six-membered aromatic ring forming part of at least one of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/06—Cobalt compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Definitions
- Patent Document 1 describes 1-acetyl-1, in the presence of an asymmetric iridium catalyst as a method for producing optically active 1-acetyl-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline. A method for reacting 2-dihydro-2,2,4-trimethyl-1-quinoline with hydrogen is described.
- An object of the present invention is to provide a more efficient method for producing a specific optically active compound, including optically active 1-acetyl-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline. To provide.
- equation (2) In the presence of an asymmetric cobalt complex, equation (2): (In the formula, R 5 represents a hydrogen atom or a C1-C6 alkyl group which may have one or more substituents, and R 6 and R 7 are independent hydrogen atoms or C1 respectively. -Representing a C6 alkyl group, R 8 represents a C1-C6 alkyl group, and R 9 , R 10 and R 11 are independent hydrogen atoms, halogen atoms, amino groups, hydroxy groups, one or more.
- C1-C6 alkyl group may have one or more substituents
- C1-C6 alkoxy group may have one or more substituents
- C2- may have one or more substituents.
- the compound represented by (3) is reacted with hydrogen.
- R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 have the same meanings as described above.
- the carbon atom marked with * represents an asymmetric carbon atom.
- the asymmetric cobalt complex according to [1] is the formula (1) :.
- each R 1 independently has a C1-C10 alkyl group which may have one or more substituents and a C3-C10 cycloalkyl group which may have one or more substituents. , Or a C6-C10 aryl group which may have one or more substituents.
- R 2 and R 3 each independently have a hydrogen atom or one or more substituents.
- one or more substituents optionally C1-C10 may be an alkyl group having a one or more substituents which may have a C1-C10 alkoxy group, A C1-C10 alkylthio group that may have one or more substituents, a C2-C11 alkoxycarbonyl group that may have one or more substituents, and one or more substituents.
- a C2-C11 alkylcarbonyl group May have a C2-C11 alkylcarbonyl group, a C6-C10 aryl group which may have one or more substituents, a halogen atom, an amino group which may be mono or dialkylated by C1-C10 alkylation, a nitro.
- N represents 0, 1, 2 or 3. When n is 0 or 1.
- a plurality of R 4 is optionally different or mutually the same as each other .
- X is a chlorine atom, a bromine atom or an iodine atom.
- the hydride reducing agent is a trialkylhydroborated boron alkali metal salt.
- a method for producing an optically active compound further comprising a step of obtaining the compound represented by.
- R 6 , R 7 and R 8 in the formula (5) are methyl groups, and R 9 , R 10 and R 11 are hydrogen atoms.
- Optically active 1, 1, 3 including a step of dissolving the optically active compound represented by the formula (5) obtained in [11] in a solvent and then optically resolution using optically active tartaric acid. -Method for producing trimethyl-4-aminoindane.
- An optically active 1,1,3-trimethyl including a step of dissolving an optically active compound represented by the formula (5) obtained in [12] in a solvent and then adding an acid for preferential crystallization. -4-Aminoindane manufacturing method.
- the formula (7) By reacting with the compound represented by, the formula (7): (In the formula, R 12 , R 13 and * have the same meanings as above.) A method for producing an optically active compound, further comprising a step of obtaining an optically active compound represented by. [17] Equation (1'): (In the formula, R 1 represents an isopropyl group or a tert-butyl group. A carbon atom marked with * represents an asymmetric carbon atom.) Asymmetric cobalt complex represented by.
- Equation (1') (In the formula, R 1 represents an isopropyl group or a tert-butyl group. A carbon atom marked with * represents an asymmetric carbon atom).
- a hydride complex obtained by reacting an asymmetric cobalt complex represented by (1) with a hydride reducing agent.
- An alkyl complex obtained by reacting an asymmetric cobalt complex represented by (1) with an alkyllithium.
- an optically active compound represented by the above formula (3) can be efficiently produced. Further, if the obtained optically active compound represented by the formula (3) is reacted with an acid and then reacted with water, the optically active compound represented by the above formula (5) can be efficiently produced. .. Further, the optically pure 1,1,3-trimethyl-4-aminoindane, which is one of the obtained optically active compounds represented by the formula (5), is optically resolved or preferentially crystallized by an acid to achieve optical purity. 1,1,3-trimethyl-4-aminoindane with high optical purity can be efficiently produced, and the obtained 1,1,3-trimethyl-4-aminoindane with high optical purity is represented by the above formula (6). By reacting with the above compound, the optically active compound represented by the above formula (7) can be efficiently produced.
- the optically active compound represented by the formula (7) is known to have a plant disease control effect (see International Publication No. 2011/162397).
- CX-CY in the present specification means that the number of carbon atoms is X to Y.
- C1-C4 means that the number of carbon atoms is 1 to 4.
- the C1-C10 alkyl group includes, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, a hexyl group and a heptyl group. , Octyl group, nonyl group, decyl group and the like.
- C1-C10 alkyl groups may have include, for example, one or more C1-C10 alkyl groups such as a phenyl group, a naphthyl group, a 4-methylphenyl group, and a 4-methoxyphenyl group.
- a C6-C10 aryl group which may have a C1-C10 alkoxy group; a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a sec-butyloxy group, a tert-butoxy group, and a tri.
- C1-C10 alkoxy group which may have one or more fluorine atoms such as a fluoromethoxy group; one or more such as a benzyloxy group, a 4-methylbenzyloxy group, and a 4-methoxybenzyloxy group.
- C1-C10 alkoxy group with C6-C10 aryl group which may have C1-C10 alkyl group or C1-C10 alkoxy group; one or more C6-C10 aryloxy groups such as 3-phenoxybenzyloxy group C1-C10 alkoxy group having a C6-C10 aryl group with; one or more C1-C10 alkyl groups or C1 such as a phenoxy group, a 2-methylphenoxy group, a 4-methylphenoxy group, and a 4-methoxyphenoxy group.
- C6-C10 aryloxy group optionally having C10 alkoxy group; C6-C10 aryloxy group having one or more C6-C10 aryloxy groups such as 3-phenoxyphenoxy group; acetyl group, propionyl One or more C1- such as a group, a benzylcarbonyl group, a 4-methylbenzylcarbonyl group, a 4-methoxybenzylcarbonyl group, a benzoyl group, a 2-methylbenzoyl group, a 4-methylbenzoyl group, and a 4-methoxybenzoyl group.
- Examples thereof include a C2-C10 acyl group which may have a C10 alkyl group or a C1-C10 alkoxy group and a C6-C10 aryl group; a carboxy group; and a fluorine atom.
- Examples of the C1-C10 alkyl group having one or more substituents include a fluoromethyl group, a trifluoromethyl group, a methoxymethyl group, an ethoxymethyl group, a methoxyethyl group, a benzyl group, a 4-fluorobenzyl group and a 4-.
- Examples thereof include a methylbenzyl group, a phenoxymethyl group, a 2-oxopropyl group, a 2-oxobutyl group, a phenacyl group, and a 2-carboxyethyl group.
- examples of the C3-C10 cycloalkyl group include a cyclopropyl group, a 2,2-dimethylcyclopropyl group, a cyclopentyl group, a cyclohexyl group, and a menthyl group.
- the substituents that these C3-C10 cycloalkyl groups may have include, for example, one or more C1-C10 alkyl groups such as a phenyl group, a naphthyl group, a 4-methylphenyl group, and a 4-methoxyphenyl group.
- a C6-C10 aryl group which may have a group or a C1-C10 alkoxy group; a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a sec-butyloxy group, a tert-butoxy group, and a group.
- C1-C10 alkoxy group which may have one or more fluorine atoms such as trifluoromethoxy group; one or more such as benzyloxy group, 4-methylbenzyloxy group, 4-methoxybenzyloxy group and the like.
- C1-C10 alkoxy group with C6-C10 aryl group which may have C1-C10 alkyl group or C1-C10 alkoxy group; one or more C6-C10 aryloxy groups such as 3-phenoxybenzyloxy group C1-C10 alkoxy group having a C6-C10 aryl group with; one or more C1-C10 alkyl groups or C1 such as a phenoxy group, a 2-methylphenoxy group, a 4-methylphenoxy group, and a 4-methoxyphenoxy group.
- C6-C10 aryloxy group optionally having C10 alkoxy group; C6-C10 aryloxy group having one or more C6-C10 aryloxy groups such as 3-phenoxyphenoxy group; acetyl group, propionyl One or more C1- such as a group, a benzylcarbonyl group, a 4-methylbenzylcarbonyl group, a 4-methoxybenzylcarbonyl group, a benzoyl group, a 2-methylbenzoyl group, a 4-methylbenzoyl group, and a 4-methoxybenzoyl group.
- Examples thereof include a C2-C10 acyl group which may have a C10 alkyl group or a C1-C10 alkoxy group and a C6-C10 aryl group; a carboxy group; and a fluorine atom.
- Examples of the C3-C10 cycloalkyl group having a substituent include a fluorocyclopropyl group, a 4-trifluorocyclohexyl group, a 4-methoxycyclopentyl group, and a 4-phenylcyclohexyl group.
- Examples of the C6-C10 aryl group in the present specification include a phenyl group and a naphthyl group.
- substituent which these C6-C10 aryl groups may have, for example, one or more of a methyl group, a fluoromethyl group, a trifluoromethyl group, a methoxymethyl group, an ethoxymethyl group, a methoxyethyl group and the like.
- C1-C10 alkoxy group or C1-C10 alkyl group which may have a fluorine atom; methoxy group, ethoxy group, propoxy group, isopropoxy group, butoxy group, isobutyloxy group, sec-butyloxy group, tert-butyloxy.
- C1 which may have one or more C1-C10 alkoxy groups or fluorine atoms such as a group, a pentyloxy group, a fluoromethoxy group, a trifluoromethoxy group, a methoxymethoxy group, an ethoxymethoxy group, and a methoxyethoxy group.
- -10 alkoxy group; C3-C10 cycloalkyloxy group such as cyclopentyloxy group; and halogen atom such as fluorine atom and chlorine atom can be mentioned.
- Examples of the C6-C10 aryl group having one or more substituents include a 2-methylphenyl group, a 4-methylphenyl group, a 4-chlorophenyl group and a 4-methoxyphenyl group.
- the C1-C10 alkoxy group which may have one or more substituents is a hydrogen atom constituting a hydroxy group (-OH) having one or more substituents described above. It is a group replaced with a C1-C10 alkyl group which may be used, and is, for example, a methoxy group, an ethoxy group, an n-propoxy group, an n-butoxy group, a sec-butoxy group, a pentyloxy group, a decyloxy group, a fluoromethoxy group, and the like.
- trifluoromethoxy group methoxymethoxy group, ethoxymethoxy group, benzyloxy group, 4-fluorobenzyloxy group, 4-methylbenzyloxy group, phenoxymethoxy group, 2-oxopropoxy group, and 2-oxobutoxy group. ..
- the C1-C10 alkylthio group which may have one or more substituents is a hydrogen atom constituting a sulfanyl group (-SH) having one or more substituents described above. It is a group that replaces the C1-C10 alkyl group that may be present, and is, for example, a methylthio group, an ethylthio group, an n-propylthio group, an n-butylthio group, a sec-butylthio group, a pentylthio group, a tidesylthio group, a fluoromethylthio group, or a tri.
- fluoromethylthio group methoxymethylthio group, ethoxymethylthio group, benzylthio group, 4-fluorobenzylthio group, 4-methylbenzylthio group, phenoxymethylthio group, 2-oxopropylthio group, and 2-oxobutylthio group. ..
- the C2-C11 alkoxycarbonyl group which may have one or more substituents is such that the hydrogen atom constituting the formyl group (-CHO) has one or more substituents described above. It is a group that replaces the C1-C10 alkoxy group that may be used, and is, for example, a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an n-butoxycarbonyl group, a sec-butoxycarbonyl group, or a tert-butoxycarbonyl group.
- the C2-C11 alkylcarbonyl group which may have one or more substituents may be such that the hydrogen atom constituting the formyl group (-CHO) has the above-mentioned substituents.
- a group that replaces the C1-C10 alkyl group for example, an acetyl group, an ethylcarbonyl group, a propylcarbonyl group, a butylcarbonyl group, a sec-butylcarbonyl group, a tert-butylcarbonyl group, a pentylcarbonyl group, a decylcarbonyl group, and a fluoro group.
- Methylcarbonyl group trifluoromethylcarbonyl group, methoxymethylcarbonyl group, ethoxymethylcarbonyl group, benzylcarbonyl group, 4-fluorobenzylcarbonyl group, 4-methylbenzylcarbonyl group, phenoxymethylcarbonyl group, 2-oxopropylcarbonyl group, And 2-oxobutylcarbonyl groups.
- the mono or dialkylated amino group is a group in which at least one of the two hydrogen atoms constituting the amino group (-NH 2 ) is replaced with the above-mentioned C1-C10 alkyl group, for example. , Methylamino group, dimethylamino group, ethylamino group and diethylamino group.
- the C1-C10 alkylsulfonyl group is a group in which the OH constituting the sulfo group (-SO 2 OH) is replaced with the above-mentioned C1-C10 alkyl group, for example, a methylsulfonyl group and an ethylsulfonyl group. Can be mentioned.
- the C6-C10 arylsulfonyl group is a group in which the OH constituting the sulfo group (-SO 2 OH) is replaced with the above-mentioned C6-C10 aryl group, for example, a phenylsulfonyl group and 4-methyl. Examples include phenylsulfonyl groups.
- the halosulfonyl group is a group in which the OH constituting the sulfo group (—SO 2 OH) is replaced with a halogen atom, and examples thereof include a fluorosulfonyl group and a chlorosulfonyl group.
- the halogen atom is a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
- the compound represented by the above formula (2) (hereinafter, may be referred to as “compound (2)” in the present specification) is reacted with hydrogen.
- a method for producing the optically active compound represented by (3) (hereinafter, may be referred to as “optically active compound (3)” in the present specification) will be described.
- the asymmetric cobalt complex used in the present invention may be a complex in which an optically active ligand is coordinated to a cobalt metal or a cobalt ion.
- asymmetric cobalt complex described in Volume 134, pp. 4651-4564 or the complex represented by the above formula (1) (hereinafter, may be referred to as “complex (1)” in the present specification) can be used.
- it is preferable to use a complex obtained by reacting the complex (1) with a reducing agent hereinafter, may be referred to as "monovalent cobalt complex (1)" in the present specification).
- Examples of the ring in which R 2 and R 3 are bonded to each other in the above formula (1) and formed together with the carbon atom to which they are bonded include cycloalkane rings such as cyclopentane ring, cyclohexane ring and cycloheptane ring. Be done. These rings may be substituted with a C1-C10 alkyl group which may have one or more substituents as described above, or a substituent which may have a C1-C10 alkyl group.
- the R 1, preferably 1 or more substituents C1-10 alkyl group which may have one or more substituents may C1-C4 alkyl group which may have a more preferred.
- R 2 and R 3 hydrogen atoms or C1-C4 alkyl groups are preferable independently of each other.
- n is preferably 2 or 3, more preferably 3.
- As X a chlorine atom or a bromine atom is preferable. It is preferable to combine these as R 1 , R 2 , R 3 and X.
- Examples of the complex (1) include dichloro [2,6-bis [4- (S) -isopropyl-2-oxazolyl] pyridine] cobalt and dichloro [2,6-bis [4- (R) -isopropyl-2-oxazolyl].
- the complex (1) is, for example, an optically active bis as a precursor according to the method described in the experimental section of the supplementary material, for example, Angelw. Chem. Int. Ed., Vol. 55, pp. 10839 (2016). It can be synthesized by mixing an oxazolinylpyridine derivative and a divalent cobalt halide in a solvent.
- the optically active bisoxazolinylpyridine derivative as a precursor can be produced, for example, according to the method described in Scheme 1 of Tetrahedron Letters, Vol. 45, p. 8988 (2004).
- the 2,6-dicarboxypyridine derivative is reacted with thionyl chloride to form the corresponding carboxylic acid chloride, which is reacted with an optically active amino alcohol to form diamide, and then reacted with thionyl chloride to form a hydroxy group.
- An optically active bisoxazolinylpyridine derivative can be produced by chlorinating and then carrying out a ring closing reaction to the oxazoline ring in NaOH / methanol.
- an asymmetric cobalt complex represented by the above formula (1') (hereinafter, may be referred to as "complex (1')" in the present specification) is preferable.
- R 1 is preferably a tert-butyl group.
- an optically active compound (3) having a high ratio of R-form is usually obtained.
- the R-form of the optically active compound represented by the above formula (7) has a higher plant disease control effect (see International Publication No. 2011/162397), and the optical compound for use as an intermediate thereof is known.
- the complex (1') is preferably an S-form.
- the complex obtained by reacting the complex (1') with the reducing agent may be referred to as a monovalent cobalt complex (1').
- optical active compounds when the compounds represented by the formulas (3), (4), (5), and (7) are referred to as “optically active compounds” or “optically active compounds”, they are referred to as “optically active compounds”. Unless otherwise specified, it means the form of a mixture of R-form and S-form in which either the R-form or S-form described later is contained in enanti-rich, or either the R-form or the S-form itself.
- the reducing agent that reacts with the complex (1) examples include a hydride reducing agent, an alkyllithium compound, and a greener reagent. It is preferably a hydride reducing agent.
- the hydride reducing agent may be any reducing agent capable of reducing the divalent cobalt atom of the complex (1) to form a hydride complex having a monovalent cobalt atom, and may be, for example, triethyl borohydride lithium or triethyl hydrogen.
- the amount of the hydride reducing agent used is usually in the range of 2 mol to 20 mol, preferably 4 mol to 10 mol, per 1 mol of the complex (1).
- the reaction is carried out by mixing the complex (1) and the hydride reducing agent in a solvent inert to the hydride reducing agent under the atmosphere of an inert gas.
- Such solvents include, for example, ether solvents such as diethyl ether, tetrahydrofuran, methyl tetrahydrofuran, 1,4-dioxane, and methyl tert-butyl ether; aliphatic hydrocarbon solvents such as n-hexane, n-heptane, and cyclohexane; Aromatic hydrocarbon solvents such as toluene, xylene, and chlorobenzene; and halogenated hydrocarbon solvents such as dichloromethane and dichloroethane can be mentioned, with ether solvents being preferred.
- the amount of the solvent used is usually in the range of 2 parts by weight to 100 parts by weight with respect to 1 part by weight of the complex (1).
- the reaction temperature is usually in the range of ⁇ 70 ° C. to 100 ° C.
- the reaction time is usually in the range of 10 minutes to 4 hours. After completion of the reaction, the obtained hydride complex may be isolated, but is usually used for the reaction between compound (2) and hydrogen without isolation.
- the alkyllithium compound may be any reducing agent capable of reducing the divalent cobalt atom of the complex (1) to form an alkyl complex having a monovalent cobalt atom, and may be, for example, methyllithium, ethyllithium, n-. Examples thereof include propyllithium and n-butyllithium.
- the amount of the alkyllithium compound used is usually in the range of 2 mol to 20 mol, preferably 3 mol to 10 mol, per 1 mol of the complex (1).
- the reaction is carried out by mixing the complex (1) and the alkyllithium compound in a solvent inert to the alkyllithium compound under an inert gas atmosphere. Further, it may be carried out in the presence of compound (2).
- Such solvents include, for example, ether solvents such as diethyl ether, tetrahydrofuran, methyl tetrahydrofuran, 1,4-dioxane, and methyl tert-butyl ether; aliphatic hydrocarbon solvents such as n-hexane, n-heptane, and cyclohexane; Aromatic hydrocarbon solvents such as toluene, xylene, and chlorobenzene; and halogenated hydrocarbon solvents such as dichloromethane and dichloroethane can be mentioned, with ether solvents being preferred.
- the amount of the solvent used is usually in the range of 2 parts by weight to 100 parts by weight with respect to 1 part by weight of the complex (1).
- the reaction temperature is usually in the range of ⁇ 70 ° C. to 100 ° C.
- the reaction time is usually in the range of 10 minutes to 4 hours. After completion of the reaction, the obtained alkyl complex may be isolated, but is usually used for the reaction between compound (2) and hydrogen without isolation.
- the greenier reagent may be any reducing agent capable of reducing the divalent cobalt atom of the complex (1) to form an alkyl complex having a monovalent cobalt atom, for example, methylmagnesium bromide, ethylmagnesium bromide, n. -Propylmagnesium bromide, n-butylmagnesium bromide and the like can be mentioned.
- the amount of the greenier reagent used is usually in the range of 2 mol to 20 mol, preferably 3 mol to 10 mol, per 1 mol of the complex (1).
- the reaction is carried out by mixing the complex (1) and the Greenier reagent in a solvent inert to the Guniryer reagent under an inert gas atmosphere.
- Such solvents include, for example, ether solvents such as diethyl ether, tetrahydrofuran, methyl tetrahydrofuran, 1,4-dioxane, and methyl tert-butyl ether; aliphatic hydrocarbon solvents such as n-hexane, n-heptane, and cyclohexane; Aromatic hydrocarbon solvents such as toluene, xylene, and chlorobenzene; and halogenated hydrocarbon solvents such as dichloromethane and dichloroethane can be mentioned, with ether solvents being preferred.
- the amount of the solvent used is usually in the range of 2 parts by weight to 100 parts by weight with respect to 1 part by weight of the complex (1).
- the reaction temperature is usually in the range of ⁇ 70 ° C. to 100 ° C.
- the reaction time is usually in the range of 10 minutes to 4 hours. After completion of the reaction, the obtained alkyl complex may be isolated, but is usually used for the reaction between compound (2) and hydrogen without isolation.
- Compound (2) can be synthesized, for example, according to the method described on page 514 of J. Chem. Soc. (C), 1966. Further, a commercially available product can also be used.
- Examples of compound (2) include 1-acetyl-1,2-dihydro-2,2,4-trimethyl-1-quinolin and 1-acetyl-1,2-dihydro-2,2,4-trimethyl-6. -Fluoro-1-quinolin, 1-acetyl-1,2-dihydro-2,2,4-trimethyl-6-ethoxy-1-quinolin, 1-acetyl-2,2-dimethyl-4-ethyl-1-quinolin , 1-Acetyl-1,2-dihydro-2,2-dimethyl-4-propyl-1-quinolin, 1-acetyl-1,2-dihydro-2,2-dimethyl-4-butyl-1-quinolin, 1 -Acetyl-1,2-dihydro-2,2-diethyl-4-methyl-1-quinolin, 1-acetyl-1,2-dihydro-2,2-dipropyl-4-methyl-1-quinolin, 1-ethyl Carbonyl-1,2-dihydro-2,2,4
- asymmetric hydrogenation reaction The reaction between compound (2) and hydrogen in the presence of an asymmetric cobalt complex (hereinafter, also referred to as “asymmetric hydrogenation reaction” in the present specification) is usually carried out in the presence of a solvent.
- a solvent include ether solvents such as diethyl ether, methyl tert-butyl ether, tetrahydrofuran, 1,4-dioxane and methyl tetrahydrofuran; halogenated hydrocarbon solvents such as chloroform and chlorobenzene; aromatic solvents such as toluene and xylene.
- nitrile solvents such as acetonitrile and propionitrile can be mentioned.
- An ether solvent is preferable, and tetrahydrofuran or 1,4-dioxane is particularly preferable.
- the amount of the solvent used is not particularly limited, and is practically 100 parts by weight or less with respect to 1 part by weight of the compound (2) in consideration of volumetric efficiency and the like.
- the asymmetric hydrogenation reaction of the present invention may be further carried out in the presence of a divalent halogenated cobalt salt or a trialkylamine. More preferred.
- a divalent cobalt halide salt include CoCl 2 , CoBr 2 and CoI 2 . It is preferably CoBr 2 .
- the amount of the divalent cobalt halide salt used is usually 2 mol or less with respect to 1 mol of the hydride complex (1).
- trialkylamines include trimethylamine, triethylamine, tripropylamine and tributylamine. Preferred is triethylamine.
- the amount of triethylamine used is usually 0.5 mol times or more and 3 mol times or less with respect to 1 mol of compound (2).
- the asymmetric hydrogenation reaction of the present invention is usually carried out by stirring a mixture containing an asymmetric cobalt catalyst and compound (2) in a hydrogen atmosphere.
- the pressure at the time of reaction may be normal pressure or may be pressurized.
- the amount of hydrogen used is usually in the range of 1 mol to 10 mol per 1 mol of compound (2).
- the reaction temperature is usually in the range of ⁇ 40 ° C. to 100 ° C., preferably in the range of ⁇ 20 ° C. to 80 ° C.
- a monovalent cobalt complex (1) When a monovalent cobalt complex (1) is used as the asymmetric cobalt complex, a separately prepared monovalent cobalt complex (1) and, if necessary, a divalent halogen are prepared in a solution prepared by dissolving compound (2) in a solvent.
- An asymmetric hydrogenation reaction may be carried out by adding a cobaltified cobalt salt or a trialkylamine and supplying hydrogen thereto, or a mixture obtained by preparing a monovalent cobalt complex (1) in the presence of a solvent. If necessary, a divalent cobalt halide salt or a trialkylamine may be added, and then compound (2) may be added, and hydrogen may be supplied thereto to carry out an asymmetric hydrogenation reaction, or a complex may be carried out.
- a hydride reducing agent, an alkyllithium compound or a greener reagent is added to a mixture containing (1), compound (2), a solvent and, if necessary, a divalent cobalt halide salt or trialkylamine to reduce the complex (1).
- the asymmetric hydrogenation reaction may be carried out by supplying hydrogen to the complex.
- the degree of progress of the reaction can be confirmed by analytical means such as gas chromatography, high performance liquid chromatography, thin layer chromatography, nuclear magnetic resonance spectrum analysis, and infrared absorption spectrum analysis.
- optically active compound (3) examples include 1-acetyl-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline and 1-acetyl-2,2,4-trimethyl-6-fluoro-. 1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2,4-trimethyl-6-ethoxy-1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2-dimethyl-4- Ethyl-1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2-dimethyl-4-propyl-1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2-dimethyl-4- Butyl-1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2-diethyl-4-methyl-1,2,3,4-tetrahydroquinoline, 1-acetyl-2,2-dipropyl-4- Methyl-1,2,3,4-tetrahydroquinoline, 1-ethyl
- the obtained reaction mixture usually contains the optically active compound (3), and after the reaction is completed, the optically active compound (3) is separated by a concentration treatment, a washing treatment, a crystallization treatment or the like. Can be taken out.
- the reaction mixture is usually concentrated and served as it is.
- optically active compound represented by the above formula (4) by reacting the optically active compound (3) with an acid (hereinafter, may be referred to as “optically active compound (4)” in the present specification. ), Then the optically active compound (4) is reacted with water, and the optically active compound represented by the above formula (5) is hereinafter referred to as “optically active compound (5)” in the present specification.
- the process of obtaining (may be) will be described.
- the reaction between the optically active compound (3) and the acid may be described as an isomerization reaction
- the reaction between the optically active compound (4) and water may be described as a hydrolysis reaction.
- the isomerization reaction can be carried out according to, for example, the method described in J. Chem. Soc. (C), 1966, p. 514 or JP-A-7-215921.
- Sulfuric acid is preferable as the acid.
- the sulfuric acid concentration is usually in the range of 90% by weight to 98% by weight, preferably in the range of 92% by weight to 97% by weight in terms of yield.
- the reaction between the optically active compound (3) and the acid is carried out in the absence of an organic solvent, and the reaction temperature is usually in the range of 20 ° C to 80 ° C.
- the amount of the acid used is usually in the range of 1 part by weight to 10 parts by weight with respect to 1 part by weight of the optically active compound (3).
- optically active compound (4) examples include N-acetyl-1,1,3-trimethyl-4-aminoindan and N-acetyl-7-fluoro-1,1,3-trimethyl-4-aminoindan.
- N-Acetyl-7-ethoxy-1,1,3-trimethyl-4-aminoindan N-acetyl-1,1-dimethyl-3-ethyl-4-aminoindan
- N-acetyl-1,1-dimethyl -3-propyl-4-aminoindan N-acetyl-1,1-dimethyl-3-butyl-4-aminoindan
- N-acetyl-1,1-dipropyl-3-methyl-4-aminoindan N- Ethylcarbonyl-1,1,3-trimethyl-4-aminoindan, N-ethylcarbonyl-1,1-dimethyl-3-ethyl-4-aminoindan, N-ethylcarbonyl
- the optically active compound (4) may be taken out from the obtained reaction mixture, but usually, the hydrolysis reaction is carried out by adding water to the obtained reaction mixture.
- the reaction temperature of the hydrolysis reaction is usually in the range of 50 ° C to 110 ° C.
- the amount of water used is usually in the range of 1 part by weight to 10 parts by weight with respect to 1 part by weight of the optically active compound (4).
- Examples of the obtained optically active compound (5) include 1,1,3-trimethyl-4-aminoindane, 7-fluoro-1,1,3-trimethyl-4-aminoindane, and 7-ethoxy-1,1.
- a solution containing the optically active compound (5) is obtained by neutralizing the obtained reaction mixture with an alkali and extracting it with an organic solvent that is immiscible with water such as toluene.
- the enantiomer ratio (R-form / S-form or S-form / R-form) of the optically active compound (5) is usually in the range of 60/40 to 90/10.
- optically active compound obtained in the above (5) of, R 6, R 7 and R 8 in an optically active 1,1,3-trimethyl-4-aminoindan (Equation (5) is a methyl group , And a compound in which R 9 , R 10 and R 11 are hydrogen atoms) is dissolved in a solvent and then optically resolved using optically active tartaric acid (hereinafter referred to as “optical resolution” in the present specification).
- optical resolution optically active tartaric acid
- optical resolution of 1,1,3-trimethyl-4-aminoindane is described in International Publication No. 2015/118793, and the optical resolution of the present invention can also be performed according to the description in this international publication.
- the optical purity is 0% e. e. From 25% e. e. (That is, 1,1,3-trimethyl-4-aminoindane, which has an enantiomer ratio (R-form / S-form or S-form / R-form) in the range of 50/50 to 62.5 / 37.5), is optically resolved. It is stated that it will be provided to.
- 1,1,3-trimethyl-4-aminoindan having high optical purity obtained through the asymmetric hydrogenation reaction, the isomerization reaction and the hydrolysis reaction described above is subjected to optical resolution. Further, 1,1,3-trimethyl-4-aminoindan having high optical purity can be obtained more efficiently.
- the optical purity of 1,1,3-trimethyl-4-aminoindane used for the optical resolution of the present invention is usually 40% e. e. From 80% e. e. (For example, 66% e.e. or more) (that is, the enantiomer ratio (R-form / S-form or S-form / R-form) is in the range of 70/30 to 90/10).
- 1,3-trimethyl-4-aminoindane preferably has a high ratio of R-form. That is, the 1,1,3-trimethyl-4-aminoindane used for the optical resolution of the present invention preferably has an enantiomer ratio of 70/30 or more in the R-form / S-form, and is 70/30 to 90 /. It is more preferably in the range of 10.
- D-tartaric acid is used as optically active tartaric acid in order to optically resolve 1,1,3-trimethyl-4-aminoindan having a high ratio of R-form to improve the ratio of R-form, and the ratio of S-form is high.
- L-tartaric acid is used as the optically active tartaric acid in order to optically resolve the high 1,1,3-trimethyl-4-aminoindan to improve the ratio of the S-form.
- the optically active tartaric acid commercially available ones can be usually used.
- the amount of optically active tartaric acid used is usually 0.7 to 1.3 mol with respect to 1 mol of optically active 1,1,3-trimethyl-4-aminoindane (total of R-form and S-form). , Preferably in the range of 0.8 to 1.2 mol.
- the solvent examples include alcohol solvents such as methanol, ethanol and 2-propanol; ether solvents such as tetrahydrofuran; nitrile solvents such as acetonitrile; ester solvents such as ethyl acetate; aromatic hydrocarbon solvents such as toluene, xylene and ethylbenzene; monochlorobenzenes.
- alcohol solvents such as methanol, ethanol and 2-propanol
- ether solvents such as tetrahydrofuran
- nitrile solvents such as acetonitrile
- ester solvents such as ethyl acetate
- aromatic hydrocarbon solvents such as toluene, xylene and ethylbenzene
- monochlorobenzenes Such as halogenated aromatic hydrocarbon solvents; aliphatic hydrocarbon solvents such as heptane and hexane; alicyclic hydrocarbon solvents such as cycl
- Alcohol solvent or water, or a mixed solvent thereof is preferable.
- the amount of the solvent used is usually in the range of 0.5 parts by weight to 10 parts by weight with respect to 1 part by weight of the optically active 1,1,3-trimethyl-4-aminoindane.
- the optical resolution of the present invention is preferably carried out by mixing an optically active 1,1,3-trimethyl-4-aminoindane with an optically active tartaric acid and a solvent.
- the mixing temperature is usually in the range of 20 ° C to 70 ° C.
- the mixing order is not particularly limited, and the optically active 1,1,3-trimethyl-4-aminoindan, the optically active tartaric acid, and the solvent may be mixed at once, or a mixture of the optically active tartaric acid and the solvent.
- optically active 1,1,3-trimethyl-4-aminoindan may be added to the optically active 1,1,3-trimethyl-4-aminoindan, or a mixture of the optically active tartaric acid and the solvent is added to the optically active 1,1,3-trimethyl-4-aminoindan.
- optically active tartaric acid may be added to a mixture of optically active 1,1,3-trimethyl-4-aminoindane and a solvent.
- optically active 1,1,3-trimethyl-4-aminoindan, optically active tartaric acid, methanol and water may be mixed at once, or optically active.
- Optically active 1,1,3-trimethyl-4-aminoindan may be added to a mixture of tartrate acid, an alcohol solvent and water, or optically active 1,1,3-trimethyl-4-aminoindan may be added to the optically active 1,1,3-trimethyl-4-aminoindan.
- a mixture of tartrate acid, an alcohol solvent and water may be added, or water may be added to a mixture of optically active tartrate acid, an alcohol solvent and optically active 1,1,3-trimethyl-4-aminoindan.
- optically active tartaric acid may be added to a mixture of optically active 1,1,3-trimethyl-4-aminoindane, an alcohol solvent and water.
- the material to be added later may be added in a total amount at a time, may be added in several portions (for example, by dropping), or may be added continuously.
- optically active tartaric acid is added to a mixture of optically active 1,1,3-trimethyl-4-aminoindane and a solvent, it is preferable to add optically active tartaric acid continuously.
- the resulting mixture is a solution, which is cooled to form crystals containing optically active 1,1,3-trimethyl-4-aminoindane and optically active tartrate. Precipitate.
- the crystals that precipitate are usually solvates.
- the temperature after cooling is lower than the above-mentioned mixing temperature, preferably in the range of ⁇ 20 ° C. to 30 ° C., and more preferably in the range of ⁇ 10 ° C. to 20 ° C.
- the cooling rate is usually in the range of 1 ° C./hour to 10 ° C./hour, and by cooling the mixture at such a cooling rate, the mixture is optically active with high optical purity of 1,1,3-trimethyl-4-aminoindane. Crystals containing tartaric acid can be precipitated.
- the cooling rate is preferably in the range of 1 ° C./hour to 8 ° C./hour, more preferably in the range of 3 ° C./hour to 6 ° C./hour.
- crystals containing optically active 1,1,3-trimethyl-4-aminoindane and optically active tartaric acid can be obtained.
- 1,1,3-trimethyl-4-aminoindane, D-tartaric acid, and methanol, which have a high ratio of R-form are mixed and optically resolved, (R) -1,1,3-trimethyl- is obtained by filtration. It can be separated into crystals containing 4-aminoindane D-tartrate in methanol and a solution containing (S) -1,1,3-trimethyl-4-aminoindane and its D-tartrate. can.
- the obtained crystals may be washed with the above-mentioned solvent as the solvent used for the optical resolution or other solvents that can be used for the optical resolution, or may be dried if necessary.
- an aqueous solution of an alkali metal hydroxide By mixing the crystals thus obtained with an aqueous solution of an alkali metal hydroxide, it can be decomposed into an optically active 1,1,3-trimethyl-4-aminoindane and an optically active alkali metal salt of tartaric acid.
- the alkali metal hydroxide include sodium hydroxide and potassium hydroxide.
- the amount of the alkali metal hydroxide used is usually in the range of 1 mol to 3 mol in terms of alkali metal with respect to 1 mol of the optically active tartaric acid used for optical resolution.
- the mixing temperature is usually in the range of 10 ° C to 80 ° C.
- Mixing of the aqueous solution of the alkali metal hydroxide may be carried out in the presence of an organic solvent.
- the organic solvent include aromatic hydrocarbon solvents such as toluene, xylene, and ethylbenzene; halogenated aromatic hydrocarbon solvents such as monochlorobenzene; aliphatic hydrocarbon solvents such as heptane and hexane; and cyclopentane and cyclohexane.
- Examples thereof include alicyclic hydrocarbon solvents; ether solvents such as diethyl ether and tert-butyl methyl ether; and ester solvents such as ethyl acetate.
- the amount of the organic solvent used is usually 10 parts by weight or less with respect to 1 part by weight of the crystal containing the optically active 1,1,3-trimethyl-4-aminoindane and the optically active tartrate.
- the mixing order is as follows: once with crystals containing optically active 1,1,3-trimethyl-4-aminoindan, optically active tartrate, an aqueous solution of alkali metal hydroxide, and if necessary, an organic solvent.
- the crystal may be added to the mixture of the crystal and the organic solvent, an aqueous solution of the alkali metal hydroxide may be added to the mixture, or the crystal may be added to the mixture of the aqueous solution of the alkali metal hydroxide and the organic solvent. May be good. Above all, it is preferable to add the crystals to a mixture of an alkali metal hydroxide and an organic solvent.
- the aqueous layer is removed from the obtained mixture, and an organic solvent is distilled off from the obtained organic layer as needed to obtain optically active 1,1,3-trimethyl-4-aminoindane. Can be taken out.
- the optical activity of the obtained 1,1,3-trimethyl-4-aminoindane is higher than that of the 1,1,3-trimethyl-4-aminoindane used for the optical resolution.
- the preferred crystallization of the present invention is the first step of mixing optically active 1,1,3-trimethyl-4-aminoindan and an achyral acid in the presence of a solvent to precipitate their acid salts, and The second step of mixing the acid salt and the base obtained in the first step to obtain an optically active 1,1,3-trimethyl-4-aminoindan is included.
- a first step of mixing an acid with a solution containing optically active 1,1,3-trimethyl-4-aminoindane to precipitate an acid salt will be described.
- the optically active 1,1,3-trimethyl-4-aminoindane used in the first step has an optical purity of 40% e. e.
- the optical purity of the optically active 1,1,3-trimethyl-4-aminoindane obtained in the second step tends to be high (usually 89% e.e.).
- the optically active 1,1,3-trimethyl-4-aminoindane preferably contains a large amount of R-form in that it is useful as a synthetic intermediate of the compound having a plant disease preventive effect described in Patent Document 1.
- the optically active 1,1,3-trimethyl-4-aminoindane used in the first step contains a large amount of R-form
- the optically active 1,1,3-trimethyl-4-amino usually obtained in the second step is obtained.
- Indan contains a lot of R-forms.
- 2,2,4-trimethyl-1-quinoline is acylated with an optically active acylating agent and then hydrogenated to be optically active.
- optically active acylating agent examples thereof include a production method in which a 2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline derivative is obtained, further isomerized with sulfuric acid, and then hydrolyzed (for example, JP-A-7-215921). See publication). Further, by asymmetric hydrogenating the 2,2,4-trimethyl-1-quinoline derivative, the above-mentioned optically active 2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline derivative can be obtained.
- optically active 1,1,3-trimethyl-4-aminoindane obtained by these methods can be provided.
- the acid may be an achiral acid, and among the optically active 1,1,3-trimethyl-4-aminoindane, a large amount of the optically active salt of the optically active substance can be preferentially precipitated. It may be an acid.
- an acid having an acid dissociation constant (pKa) of less than 2.8 is usually used.
- the acid dissociation constant is determined by the equilibrium constant (Ka) of the ionization equilibrium of the acid when the acid dissociation reaction in which hydrogen ions are released from the acid, or the dissociation constant (pKa) which is a negative common logarithm thereof. It is an index showing the strength of acid expressed.
- Acids with an acid dissociation constant (pKa) of less than 2.8 include sulfuric acid, hydrogen sulfate, sulfamic acid, organic sulfonic acid, hydrohalogenate, phosphoric acid, organic phosphoric acids, nitrate, tetrafluoroboric acid and carboxylic acid. Acids are mentioned, and it is preferable to use one or more acids selected from the group consisting of these acids.
- the hydrogen sulfate include hydrogen sulfate alkali metal salts such as sodium hydrogen sulfate, lithium hydrogen sulfate, and potassium hydrogen sulfate.
- Examples of the organic sulfonic acid include methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, taurine and the like.
- Examples of the hydrohalic acid include hydrochloric acid, hydrobromic acid, and hydrobromic acid.
- Examples of organic phosphoric acids include phenyl dihydrogen phosphate, ethyl dihydrogen phosphate, phenylphosphonic acid, and methylphosphonic acid.
- carboxylic acid examples include oxalic acid, trichloroacetic acid, trifluoroacetic acid, dichloroacetic acid, monochloroacetic acid, monobromoacetic acid, 2-nitrobenzoic acid, pentafluorophenylcarboxylic acid and the like.
- one or more acids selected from the group consisting of sulfuric acid, hydrogen sulfate, sulfamic acid, organic sulfonic acid, hydrohalic acid, phosphoric acid, organic phosphoric acids, nitric acid, tetrafluoroboric acid, and carboxylic acid. It is more preferable to use it.
- Sulfuric acid sodium hydrogensulfate, potassium hydrogensulfate, sulfamic acid, methanesulfonic acid, p-toluenesulfonic acid, benzenesulfonic acid, hydrochloric acid, hydrobromic acid, phosphoric acid, phenylphosphate, dihydrogenphobic phenyl, nitrate, tetra It is further preferred to use one or more acids selected from the group consisting of fluoroboric acid, oxalic acid, trifluoroacetic acid, trichloroacetic acid, 2-nitrobenzoic acid, chloroacetic acid, and bromoacetic acid.
- Sulfuric acid sodium hydrogensulfate, potassium hydrogensulfate, sulfamic acid, methanesulfonic acid, p-toluenesulfonic acid, benzenesulfonic acid, hydrochloric acid, hydrobromic acid, phosphoric acid, phenylphosphate, dihydrogenphobic phenyl, nitrate, tetra It is even more preferred to use one or more acids selected from the group consisting of fluoroboric acid, oxalic acid, trifluoroacetic acid, trichloroacetic acid, and 2-nitrobenzoic acid.
- the amount of the acid used is usually 0.7 mol to 1.5 mol, preferably 0 in the case of an acid other than sulfuric acid, with respect to 1 mol of optically active 1,1,3-trimethyl-4-aminoindan.
- the range is from 7.7 mol to 1.0 mol, and in the case of sulfuric acid, it is usually in the range of 0.35 mol to 0.5 mol, preferably 0.35 mol to 0.45 mol.
- the solvent examples include alcohol solvents such as methanol, ethanol, and 2-propanol; water; ether solvents such as tetrahydrofuran; nitrile solvents such as acetonitrile; ester solvents such as ethyl acetate; aromatic hydrocarbons such as toluene, xylene, and ethylbenzene. Solvents; halogenated aromatic hydrocarbon solvents such as monochlorobenzene; aliphatic hydrocarbon solvents such as heptane and hexane; and alicyclic hydrocarbon solvents such as cyclopentane and cyclohexane, alcohol solvents and aromatics.
- a hydrocarbon solvent and water are preferable.
- the amount of the solvent used is usually in the range of 0.5 parts by weight to 20 parts by weight, preferably 1.0 part by weight to 10 parts by weight with respect to 1 part by weight of 1,1,3-trimethyl-4-aminoindane. Is.
- the mixing temperature is usually in the range of 20 ° C to 100 ° C.
- the mixing order may be that 1,1,3-trimethyl-4-aminoindane, an acid and a solvent may be mixed at one time, or after mixing the acid and the solvent, the resulting mixture may be mixed with 1,1,1. 3-trimethyl-4-aminoindane may be added. A mixture of an acid and a solvent may be added to 1,1,3-trimethyl-4-aminoindane. Further, after mixing 1,1,3-trimethyl-4-aminoindane with a solvent, an acid or a mixture of an acid and a solvent may be added to the obtained mixture.
- a method of mixing 1,1,3-trimethyl-4-aminoindane with a solvent and then adding an acid or a mixture of the acid and the solvent to the obtained mixture is preferable. If the crystals do not precipitate even after mixing and cooling, the crystals may be precipitated by partially distilling off the solvent.
- Mixing may be performed collectively, continuously, or divided (for example, dropped).
- an acid is added to a mixture of 1,1,3-trimethyl-4-aminoindane and a solvent, the acid may be added all at once or continuously, but may be added in portions. Is preferable.
- a salt of optically active 1,1,3-trimethyl-4-aminoindane may be precipitated only by mixing an acid with a solution of optically active 1,1,3-trimethyl-4-aminoindane. Usually, by cooling the resulting mixture, the optically active acid salt of 1,1,3-trimethyl-4-aminoindane can be precipitated. By separating the salt precipitated from the mixture by a solid-liquid separation treatment such as filtration, the acid salt of optically active 1,1,3-trimethyl-4-aminoindane and the remaining 1,1,3-trimethyl are obtained. It can be separated into a solution containing -4-aminoindane and its acid salt. If the optically active acid salt of 1,1,3-trimethyl-4-aminoindane does not precipitate even after cooling, the salt may be precipitated by distilling off a part of the solvent.
- the temperature after cooling is lower than the above-mentioned mixing temperature, preferably in the range of ⁇ 20 ° C. to 30 ° C., and more preferably in the range of ⁇ 10 ° C. to 20 ° C.
- the cooling rate is not particularly limited, but is usually in the range of about 1 ° C./hour to 100 ° C./hour.
- optically active acid salt of 1,1,3-trimethyl-4-aminoindane extracted in the first step may be used as it is in the next second step, but at least one selected from the above solvents. It may be served after washing with the solvent of. Further, it may be dried and then subjected to the second step if necessary.
- any base having a base strength capable of decomposing the optically active acid salt of 1,1,3-trimethyl-4-aminoindane can be used without particular limitation.
- the base include an inorganic base and an organic base.
- the inorganic base include alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal carbonates, alkaline earth metal carbonates, and alkali metals phosphate.
- the alkali metal hydroxide include sodium hydroxide and potassium hydroxide.
- Examples of the alkaline earth metal hydroxide include calcium hydroxide and magnesium hydroxide.
- Examples of the alkali metal carbonate include potassium carbonate and sodium carbonate.
- Alkaline carbonate earth metals include calcium carbonate and magnesium carbonate.
- alkali metal phosphate examples include trisodium phosphate and tripotassium phosphate.
- Alkali metal hydroxides are preferred.
- organic bases include tertiary amines, secondary amines, and primary amines.
- tertiary amine examples include triethylamine, tripropylamine, tributylamine and the like.
- secondary amine examples include diethylamine, dipropylamine, dibutylamine and the like.
- Examples of the primary amine include butylamine and benzylamine. It is preferably a tertiary amine.
- the amount of the base is usually in the range of 0.5 mol to 3 mol in terms of base with respect to 1 mol of the acid used in the first step.
- the mixing temperature is usually in the range of 10 ° C to 80 ° C.
- the mixing of the salt and the base obtained in the first step may be carried out in the presence of an organic solvent and / or water.
- organic solvent include aromatic hydrocarbon solvents such as toluene, xylene and ethylbenzene; halogenated aromatic hydrocarbon solvents such as monochlorobenzene; aliphatic hydrocarbon solvents such as heptane and hexane; alicyclic type such as cyclopentane and cyclohexane.
- examples include, but are not limited to, hydrocarbon solvents; ether solvents such as diethyl ether and tert-butyl methyl ether; and ester solvents such as ethyl acetate; and mixed solvents thereof.
- the total amount of the organic solvent and / or water used is usually 10 parts by weight or less with respect to 1 part by weight of the salt.
- the mixing order may be such that the optically active acid salt of 1,1,3-trimethyl-4-aminoindan, the base in an aqueous solution if necessary, and the organic solvent if necessary may be mixed at once.
- the acid salt and, if necessary, a mixture with an organic solvent, and if necessary, an aqueous solution of the base may be mixed.
- the acid salt may be added to a mixture of an aqueous solution of a base and an organic solvent, if necessary.
- the mixture After completion of mixing, the mixture is usually separated into an organic layer and an aqueous layer, which are separated to obtain an organic layer, and if necessary, an organic solvent is distilled off to obtain an optically active 1, 1,3-trimethyl-4-aminoindane can be taken out.
- the optical purity of the optically active 1,1,3-trimethyl-4-aminoindane thus obtained is usually the optically active 1,1,3-trimethyl-4-aminoindane used in the first step. Higher than the optical purity of.
- the optically active 1,1,3-trimethyl-4-aminoindan is used for the amidation reaction D described later, the acid salt is subjected to the reaction with the compound represented by the formula (1-3) as it is.
- the acid salt is neutralized by the base in the reaction system to give optically active 1,1,3-trimethyl-4-aminoindan, which reacts with the compound represented by the formula (1-3). Therefore, the second step of the present invention and the amidation reaction D can be continuously performed.
- optically active 1,1,3-trimethyl-4- obtained through the above-mentioned asymmetric hydrogenation reaction, isomerization reaction and hydrolysis reaction, and optionally optical resolution (or preferential crystallization).
- An optically active compound represented by the above formula (7) by reacting an aminoindan with a compound represented by the above formula (6) (hereinafter, may be referred to as “compound (6)” in the present specification). (In the present specification, hereinafter, it may be referred to as “optically active compound (7)”) will be described.
- the reaction between the optically active 1,1,3-trimethyl-4-aminoindane and the compound (6) may be referred to as an “amidation reaction”.
- R 12 in the above formula (6) is preferably a hydrogen atom or a methyl group, and more preferably a hydrogen atom.
- R 13 is preferably a methyl group, a monofluoromethyl group, a difluoromethyl group or a trifluoromethyl group, and more preferably a difluoromethyl group.
- R 14 is preferably a chlorine atom, an ethoxy group and a hydroxy group, and more preferably a chlorine atom.
- Examples of compound (6) include ethyl 1-methyl-3-difluoromethylpyrazole-4-carboxylate, 1-methyl-3-difluoromethylpyrazole-4-carboxylic acid, and 1-methyl-3-difluoromethylpyrazole-4. -Cylic acid chloride and the like can be mentioned.
- the obtained optically active compound (7) includes (R)-(-)-N- (1,1,3-trimethylindan-4-yl) -1-methyl-3-difluoromethylpyrazole-4-carboxylic acid.
- Examples include amides.
- the amidation reaction may be carried out under the condition that the optically active 1,1,3-trimethyl-4-aminoindane reacts with the compound (6), but the amidation reaction A, B, C or D described below may be used. It is preferable to have.
- Amidation reaction A is an optically active 1,1,3-trimethyl-4-aminoindan compounds
- R 14 is a hydroxy group in the formula (6) (herein, the following "Compound (6- 1) ”) is a reaction to obtain an optically active compound (7) in the presence of a dehydration condensing agent.
- Compound (6- 1) is a reaction to obtain an optically active compound (7) in the presence of a dehydration condensing agent.
- dehydration condensing agent examples include 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride, carbodiimide compounds such as 1,3-dicyclohexylcarbodiimide, and (benzotriazole-1-yloxy) tris (dimethylamino). Phosphonium hexafluorophosphate may be mentioned.
- the amount of the dehydration condensing agent used is usually in the range of 1 mol to 5 mol per 1 mol of compound (6-1).
- the amount of optically active 1,1,3-trimethyl-4-aminoindane used is usually in the range of 0.5 mol to 3 mol per 1 mol of compound (6-1).
- the reaction between the optically active 1,1,3-trimethyl-4-aminoindane and compound (6-1) is usually carried out in the presence of a solvent inert to the reaction.
- solvents include ether solvents such as tetrahydrofuran, dioxane, ethylene glycol dimethyl ether, and tert-butyl methyl ether; aliphatic hydrocarbon solvents such as hexane, heptane, octane; aromatic hydrocarbons such as toluene, xylene, and ethylbenzene.
- Solvent Halogened hydrocarbon solvent such as chlorobenzene; Ester solvent such as butyl acetate and ethyl acetate; Nitrile solvent such as acetonitrile; Acid amide solvent such as N, N-dimethylformamide; Sulfoxide solvent such as dimethyl sulfoxide, and pyridine Such as nitrogen-containing aromatic compound solvents; as well as mixed solutions of two or more of these.
- the amount of the solvent used is usually in the range of 1 part by weight to 20 parts by weight with respect to 1 part by weight of the compound (6-1).
- the reaction temperature is usually in the range of ⁇ 20 ° C. to 150 ° C., and the reaction time is usually in the range of 1 hour to 24 hours.
- an aqueous solution of a base such as an aqueous solution of sodium hydrogen carbonate, an aqueous solution of sodium carbonate, an aqueous solution of ammonium chloride, an aqueous solution of sodium hydroxide, or an aqueous solution of potassium hydroxide; or an aqueous solution of hydrochloric acid, sulfuric acid, or phosphoric acid.
- an aqueous solution of an acid such as acetic acid is mixed to precipitate a solid, and the obtained mixture is filtered to take out the optically active compound (7).
- the optically active compound (7) can be taken out by extracting the obtained mixture with an organic solvent and performing post-treatment operations such as separating, drying and concentrating the organic layer.
- the organic layer is water: aqueous solution of alkali metal hydrogen carbonate such as sodium hydrogen carbonate aqueous solution: aqueous solution of alkali metal carbonate such as sodium carbonate aqueous solution: ammonium chloride aqueous solution: alkali metal water such as sodium hydroxide aqueous solution and potassium hydroxide aqueous solution.
- Aqueous solution of oxide Alternatively, it may be washed with an aqueous solution of an acid such as hydrochloric acid, sulfuric acid, phosphoric acid and acetic acid. Cleaning of the organic layer is usually carried out in the range of 0 ° C to 70 ° C, preferably 20 ° C to 60 ° C.
- the extracted optically active compound (7) can be further purified by column chromatography, recrystallization and the like.
- the amidation reaction B is a step of reacting the optically active 1,1,3-trimethyl-4-aminoindane with the compound (6-1) in the presence of Lewis acid to obtain the optically active compound (7). be.
- metal chlorides such as titanium tetrachloride, zirconium tetrachloride, and aluminum chloride: titanium ethoxydo, titanium propoxide, zirconium ethoxide, zirconium propoxide, aluminum ethoxydo, aluminum propoxide, antimonate,
- metal alkoxide compounds such as antimonpropoxide: tetrakis (dimethylamino) titanium, dichlorobis (dimethylamino) titanium, and metal amide compounds such as tetrakis (diethylamino) titanium: boric acid, 3,5-bis (trifluoromethyl) phenyl.
- Boron compounds such as boronic acid, 2,4-bis (trifluoromethyl) phenylboronic acid, and pentafluorophenylboronic acid: triphenylmethyltetrakis (pentafluorophenyl) borate, triphenylmethyltetrakis (3,5-bistrifluoro) Examples thereof include borate compounds such as methylphenyl) borate and N, N-dimethylanilinium tetrakis (pentafluorophenyl) borate.
- the amount of Lewis acid used is usually in the range of 0.001 mol to 3 mol per 1 mol of compound (6-1).
- the amount of optically active 1,1,3-trimethyl-4-aminoindane used is usually in the range of 0.5 mol to 3 mol per 1 mol of compound (6-1).
- the reaction of the optically active 1,1,3-trimethyl-4-aminoindane with compound (6-1) is usually carried out in the presence of a solvent inert to the reaction.
- a solvent inert examples include the above-mentioned solvents as the solvents that can be used for the amidation reaction A.
- the amount of the solvent used is usually in the range of 1 part by weight to 20 parts by weight with respect to 1 part by weight of the compound (6-1).
- the reaction temperature is usually in the range of ⁇ 20 ° C. to 150 ° C.
- the reaction time is usually in the range of 1 hour to 120 hours, and it is preferable to carry out the reaction while removing the by-product water.
- the optically active compound (7) can be taken out by performing the same treatment as in the amidation reaction A.
- Amidation reaction C is an optically active 1,1,3-trimethyl-4-aminoindan and the above formula wherein R 14 is 1 in (6) one or more optionally substituted C1-C10 alkoxy group with a halogen atom
- a step of reacting a compound hereinafter, may be referred to as “compound (6-2)” in the present specification
- compound (6-2) may be referred to as “compound (6-2)” in the present specification
- a Lewis acid or a Lewis base to obtain an optically active compound (7).
- Lewis acids include metal chlorides such as titanium tetrachloride, zirconium tetrachloride, and aluminum chloride, and titanium ethoxide, titanium propoxide, zirconium ethoxide, zirconium propoxide, aluminum ethoxydo, aluminum propoxide, and antimonate. And metal alkoxide compounds such as antimonpropoxide.
- the amount of Lewis acid used is usually in the range of 0.01 to 3 mol per 1 mol of compound (6-2).
- the amount of optically active 1,1,3-trimethyl-4-aminoindane used is usually in the range of 0.5 mol to 3 mol per 1 mol of compound (6-2).
- Lewis bases include metal alkoxide compounds such as sodium methoxyd, sodium ethoxydo, sodium tert-butoxide, potassium methoxyd, potassium ethoxydo and potassium tert-butoxide: metal hydrides such as sodium hydride: lithium diisopropylamide and tert.
- -Lithium compounds such as butyl lithium: silicon compounds such as sodium hexamethyldisilazane and potassium hexamethyldisilazane: aluminum compounds such as trimethylaluminum, triethylaluminum and triisobutylaluminum.
- the amount of Lewis base used is usually in the range of 0.01 mol to 3 mol per 1 mol of compound (6-2).
- the amount of optically active 1,1,3-trimethyl-4-aminoindane used is usually in the range of 0.5 mol to 3 mol per 1 mol of compound (6-2).
- the reaction of the optically active 1,1,3-trimethyl-4-aminoindane with compound (6-2) is usually carried out in the presence of a solvent inert to the reaction.
- a solvent inert examples include the above-mentioned solvents as the solvents that can be used for the amidation reaction A.
- the amount of the solvent used is usually in the range of 1 part by weight to 20 parts by weight with respect to 1 part by weight of the compound (6-2).
- the reaction temperature is usually in the range of ⁇ 20 ° C. to 150 ° C., and the reaction time is usually in the range of 1 hour to 110 hours, and it is preferable to carry out the reaction while removing the by-product alcohol.
- the optically active compound (7) can be taken out by performing the same treatment as in the amidation reaction A.
- Amidation reaction D a compound R 14 is a halogen atom in the optically active 1,1,3-trimethyl-4-aminoindan and the formula (6) (herein, the following, "compound (6-3 ) ”) Is a step of reacting with the presence of a base to obtain an optically active compound (7).
- compound (6-3 ) a compound of formula (6)
- R 12 and R 13 have the same meanings as described above, and R 14'' represents a halogen atom.
- the base examples include alkali metal carbonates such as sodium carbonate and potassium carbonate; tertiary amines such as triethylamine and diisopropylethylamine; and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
- the amount of the base used is usually in the range of 5 mol, preferably 1 mol to 3 mol, from the catalytic amount, relative to 1 mol of the optically active 1,1,3-trimethyl-4-aminoindane.
- the amount of compound (6-3) used is usually 0.5 mol to 1.5 mol, preferably 0.8 mol, relative to 1 mol of optically active 1,1,3-trimethyl-4-aminoindan. From 1.3 mol, more preferably in the range of 1.0 mol to 1.2 mol.
- the reaction between the optically active 1,1,3-trimethyl-4-aminoindane and compound (6-3) is usually carried out in the presence of a solvent.
- the solvent may be any one inert to the reaction, for example, an aliphatic hydrocarbon solvent such as pentane, hexane, heptane, octane and cyclohexane; an aromatic hydrocarbon solvent such as toluene, xylene and ethylbenzene; dichloromethane, chloroform.
- 1,2-Dichloroethane and halogenated aliphatic hydrocarbon solvents such as carbon tetrachloride; halogenated aromatic hydrocarbon solvents such as chlorobenzene, dichlorobenzene and trichlorobenzene; diethyl ether, diisopropyl ether, tert-butylmethyl ether, cyclohexyl Ether solvents such as methyl ether, ethylene glycol dimethyl ether, tetrahydrofuran and dioxane; ester solvents such as ethyl acetate and butyl acetate; nitrile solvents such as acetonitrile; and mixed solutions of two or more of these include aromatic hydrocarbon solvents.
- aromatic hydrocarbon solvents such as carbon tetrachloride
- halogenated aromatic hydrocarbon solvents such as chlorobenzene, dichlorobenzene and trichlorobenzene
- Halogenized aromatic hydrocarbon solvents and ether solvents are preferred, with toluene, xylene, ethylbenzene, chlorobenzene and tetrahydrofuran more preferred.
- the amount of the solvent used is preferably in the range of 1 part by weight to 20 parts by weight, more preferably 2 parts by weight to 10 parts by weight, based on 1 part by weight of the optically active 1,1,3-trimethyl-4-aminoindane. Is.
- the reaction temperature is usually in the range of ⁇ 20 ° C. to 80 ° C., preferably 0 ° C. to 70 ° C., more preferably 20 ° C. to 60 ° C., and the reaction time is usually in the range of 0.1 hour to 24 hours.
- the optically active compound (7) can be taken out by performing the same treatment as in the amidation reaction A.
- the extracted optically active compound (7) can be further purified by column chromatography, recrystallization and the like, and is preferably purified.
- a purification method a method in which the optically active compound (7) is dissolved in a solvent to prepare a solution and recrystallization is performed using the solution is preferable. Seed crystals may be used for recrystallization.
- Such solvents include aliphatic hydrocarbon solvents such as pentane, hexane, heptane, octane and cyclohexane; aromatic hydrocarbon solvents such as toluene, xylene and ethylbenzene; dichloromethane, chloroform, 1,2-dichloroethane and carbon tetrachloride and the like.
- Halogenated aliphatic hydrocarbon solvent Halogenized aromatic hydrocarbon solvent such as chlorobenzene, dichlorobenzene and trichlorobenzene; diethyl ether, diisopropyl ether, tert-butylmethyl ether, cyclohexylmethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran and dioxane and the like.
- Ether solvents include aliphatic hydrocarbon solvents, Aromatic hydrocarbon solvents, halogenated aromatic hydrocarbon solvents and ester solvents are preferred, with toluene, xylene, ethylbenzene, hexane, heptane and ethyl acetate more preferred.
- Example 1 ⁇ Synthesis of dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt> 2.37 g of 2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine and 43 g of tetrahydrofuran were placed in a 100 mL flask equipped with a nitrogen-substituted reflux condenser, and stirred at 25 ° C. for 2 , 6-Bis [4- (S) -t-butyl-2-oxazolyl] pyridine was confirmed to be dissolved.
- Example 2 ⁇ Synthesis of dibromo [2,6-bis [4- (S) -isopropyl-2-oxazolyl] pyridine] cobalt>
- Example 1 instead of 2.37 g of 2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine, 2,6-bis [4- (S) -isopropyl-2-oxazolyl] ]
- the same procedure as in Example 1 was carried out except that 2.16 g of pyridine was used to obtain 3.17 g of blue-green powder. Yield: 85%
- Example 3 ⁇ Synthesis of dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] -4-methoxypyridin] cobalt>
- Example 1 instead of 2.37 g of 2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine, 2,6-bis [4- (S) -isobutyl-2-oxazolyl] ] -Except for using 2.59 g of 4-methoxypyridine, the same procedure as in Example 1 was carried out to obtain 3.54 g of a blue-green powder. Yield: 85%
- Example 4 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 88 mg, 1-acetyl-1,2-dihydro-2, in a 100 mL autoclave with a glass inner tube. 3.44 g of 2,4-trimethyl-1-quinoline and 11.5 g of tetrahydrofuran were charged.
- Example 5 ⁇ Dichloro [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine]
- Asymmetric hydrogenation reaction with cobalt hydride reduction complex > Dichloro [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 74 mg, 1-acetyl-1,2-dihydro-2, in a 100 mL autoclave with a glass inner tube. 3.44 g of 2,4-trimethyl-1-quinoline and 11.5 g of tetrahydrofuran were charged.
- Example 6 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> In a 100 mL autoclave with a glass inner tube, dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 44 mg, 1-acetyl-1,2-dihydro-2, 6.89 g of 2,4-trimethyl-1-quinoline, 17.5 mg of cobalt (II) bromide and 11.5 g of tetrahydrofuran were charged.
- Example 8 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 88 mg, 1-acetyl-1,2-dihydro-2, in a 100 mL autoclave with a glass inner tube. 6.89 g of 2,4-trimethyl-1-quinoline, 35 mg of cobalt (II) bromide and 11.5 g of tetrahydrofuran were charged.
- Example 9 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> In a 100 mL autoclave with a glass inner tube, dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 44 mg, 1-acetyl-1,2-dihydro-2, 6.89 g of 2,4-trimethyl-1-quinoline, 3.85 g of triethylamine and 8.2 g of 1,4-dioxane were charged.
- Example 10 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 22 mg, 1-acetyl-1,2-dihydro-2, in a 100 mL autoclave with a glass inner tube. 3.44 g of 2,4-trimethyl-1-quinoline, 1.93 g of triethylamine and 4.1 g of 1,4-dioxane were charged.
- Example 11 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 88 mg, 1-acetyl-1,2-dihydro-2, in a 100 mL autoclave with a glass inner tube. 13.8 g of 2,4-trimethyl-1-quinoline, 35 mg of cobalt (II) bromide and 16.5 g of 1,4-dioxane were charged.
- Example 12 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> In a 100 mL autoclave with a glass inner tube, dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 44 mg, 1-acetyl-1,2-dihydro-2, 6.89 g of 2,4-trimethyl-1-quinoline and 8.2 g of 1,4-dioxane were charged.
- Example 13 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> In a 100 mL autoclave with a glass inner tube, dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt 44 mg, 1-acetyl-1,2-dihydro-2, 7.5 g of 2,4-trimethyl-6-fluoro-1-quinoline and 8.2 g of 1,4-dioxane were charged.
- Example 14 ⁇ Dibromo [2,6-bis [4- (S) -isopropyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with cobalt hydride reduction complex> Dibromo [2,6-bis [4- (S) -isopropyl-2-oxazolyl] pyridine] cobalt 52 mg, 1-acetyl-1,2- prepared in Example 2 in a 100 mL autoclave with a glass inner tube. 4.31 g of dihydro-2,2,4-trimethyl-1-quinoline, 2.6 g of triethylamine and 10.1 g of 1,4-dioxane were charged.
- Example 15 ⁇ Asymmetric hydrogenation reaction of dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] -4-methoxypyridin] cobalt with hydride reduction complex> Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] -4--4methoxypyridine] cobalt 58 mg prepared in Example 3 in a 100 mL autoclave with a glass inner tube. -Acetyl-1,2-dihydro-2,2,4-trimethyl-1-quinoline 4.31 g, triethylamine 2.6 g and 1,4-dioxane 10.1 g were charged.
- Example 16 ⁇ Dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] Asymmetric hydrogenation reaction with a methyl reduction complex of cobalt> Add 219 mg of dibromo [2,6-bis [4- (S) -t-butyl-2-oxazolyl] pyridine] cobalt, 1,4-dioxane 2 g, and 2 g of toluene to a Schlenk tube in a nitrogen atmosphere, and bring the temperature to -40 ° C. Cooled.
- Example 17 ⁇ Synthesis of optically active 1,1,3-trimethyl-4-aminoindane>
- 1-acetyl-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline having an R-form ratio of 77.7% obtained in the same manner as in Example 4 or 6 50 g of a tetrahydrofuran solution was charged, and tetrahydrofuran was distilled off.
- the flask in which 13.3 g (content 85%) of the concentrate remained was replaced with nitrogen, 22.7 g of 98% sulfuric acid and 260 mg of water were charged at room temperature, and the mixture was heated and stirred at 45 ° C. for 6 hours.
- Example 18 Optical resolution of 1,1,3-trimethyl-4-aminoindane using d-tartaric acid>
- the obtained concentrate was optically active 1,1,3-trimethyl-4-aminoindane, and 12.1 g was obtained.
- Example 20 ⁇ Optical resolution of 1,1,3-trimethyl-4-aminoindane using d-tartaric acid>
- the temperature was raised to ° C.
- the solution obtained by dissolving 9.8 g of d-tartaric acid in 23 g of water was added dropwise at 60 ° C. over 30 minutes.
- Example 25 Synthesis of (R) -1,1,3-trimethyl-4-aminoindane by decomposition of (R) -1,1,3-trimethyl-4-aminoindane / d-tartaric acid methanol solvate salt>
- 10 g of toluene were charged and the mixture was stirred at room temperature for 30 minutes.
- Example 26 ⁇ Amidation reaction D> 14.0 parts of 1-methyl-3-difluoromethylpyrazole-4-carboxylic acid and 35.1 parts of xylene were mixed under a nitrogen atmosphere at room temperature. The resulting mixture was heated to 100 ° C. 11.2 parts of thionyl chloride was added dropwise to the obtained mixture over 5 hours. The resulting mixture was stirred at 100 ° C. for 15 hours and then cooled to 40 ° C. Thionyl chloride and xylene were distilled off from the obtained reaction mixture under reduced pressure to obtain brown 1-methyl-3-difluoromethylpyrazole-4-carboxylic acid chloride.
- optically active (R) -1,1,3-trimethyl-4-aminoindane can be efficiently produced.
- Such a compound prepares (R)-(-)-(1,1,3-trimethylindan-4-yl) -1-methyl-3-difluoromethylpyrazole-4-carboxylic acid amide having a plant disease preventive effect.
- the present invention also provides an asymmetric cobalt complex that can be used to produce precursors of such intermediates.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
[1] 不斉コバルト錯体の存在下、式(2):
(式中、R5は、水素原子、または1つ以上の置換基を有していてもよいC1-C6アルキル基を表し、R6及びR7は、それぞれ独立して、水素原子、またはC1-C6アルキル基を表し、R8は、C1-C6アルキル基を表し、そしてR9、R10およびR11は、それぞれ独立して、水素原子、ハロゲン原子、アミノ基、ヒドロキシ基、1つ以上の置換基を有していてもよいC1-C6アルキル基、1つ以上の置換基を有していてもよいC1-C6アルコキシ基、1つ以上の置換基を有していてもよいC2-C7アルキルカルボニル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表す。)
で示される化合物と水素とを反応させる、式(3):
(式中、R5、R6、R7、R8、R9、R10およびR11は、それぞれ上記と同じ意味を表す。*が付された炭素原子は、不斉炭素原子を表す。)
で示される光学活性な化合物の製造方法。
[2] [1]に記載の不斉コバルト錯体が、式(1):
(式中、R1は各々独立して、1つ以上の置換基を有していてもよいC1-C10アルキル基、1つ以上の置換基を有していてもよいC3-C10シクロアルキル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表す。R2およびR3は、それぞれ独立して、水素原子、1つ以上の置換基を有していてもよいC1-C10アルキル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表すか、または、R2とR3とが互いに結合して、それらが結合する炭素原子とともに環を形成している。R4は、1つ以上の置換基を有していてもよいC1-C10アルキル基、1つ以上の置換基を有していてもよいC1-C10アルコキシ基、1つ以上の置換基を有していてもよいC1-C10アルキルチオ基、1つ以上の置換基を有していてもよいC2-C11アルコキシカルボニル基、1つ以上の置換基を有していてもよいC2-C11アルキルカルボニル基、1つ以上の置換基を有していてもよいC6-C10アリール基、ハロゲン原子、C1-C10アルキル化でモノもしくはジアルキル化されていてもよいアミノ基、ニトロ基、ヒドロキシ基、スルホ基、C1-C10アルキルスルホニル基、C6-C10アリールスルホニル基、またはハロスルホニル基を表す。nは0、1、2または3を表す。nが0または1である場合、複数のR4は互いに同一であっても相異なっていてもよい。Xは、塩素原子、臭素原子またはヨウ素原子を表す。そして、*が付された炭素原子は、不斉炭素原子を表す。)
で示される不斉コバルト錯体と、還元剤を反応させて得られる1価のコバルト錯体である、[1]記載の製造方法。
[3] 還元剤が、ヒドリド還元剤で、1価のコバルト錯体がヒドリド錯体である、[2]記載の製造方法。
[4] ヒドリド還元剤が、トリアルキル水素化ホウ素アルカリ金属塩である、[3]記載の製造方法。
[5] さらに、2価のハロゲン化コバルト塩の存在下で反応を実施する、[3]または[4]記載の製造方法。
[6] ヒドリド錯体1モルに対し、2価のハロゲン化コバルト塩の使用量が2モル以下である、[5]記載の製造方法。
[7] さらに、トリアルキルアミンの存在下で反応を実施する、[3]または[4]記載の製造方法。
[8] 式(2)で表される化合物1モルに対し、トリアルキルアミンの使用量が0.5モルから3モルの範囲である、[7]記載の製造方法。
[9] 還元剤が、アルキルリチウムで、1価のコバルト錯体がアルキル錯体である、[2]記載の製造方法。
[10] [1]~[9]のいずれかの製造方法で得られた式(3)で示される光学活性な化合物と酸とを反応させて、式(4):
(式中、R5、R6、R7、R8、R9、R10およびR11は、それぞれ上記と同じ意味を表す。*が付された炭素原子は、不斉炭素原子を表す。)
で示される光学活性な化合物を得る工程、及び、
得られた式(4)で示される光学活性な化合物と水とを反応させて、式(5):
(式中、R6、R7、R8、R9、R10およびR11は、それぞれ上記と同じ意味を表す。*が付された炭素原子は、不斉炭素原子を表す。)
で示される化合物を得る工程をさらに含む、光学活性な化合物の製造方法。
[11] 式(5)におけるR6、R7およびR8がメチル基であり、そして、R9、R10およびR11が水素原子である、[10]記載の製造方法。
[12] [11]で得た式(5)で示される光学活性な化合物を溶媒に溶解させた後、光学活性な酒石酸を用いて光学分割する工程を含む、光学活性な1,1,3-トリメチル-4-アミノインダンの製造方法。
[13] [12]で得た式(5)で示される光学活性な化合物を溶媒に溶解させた後、酸を加えて優先晶析させる工程を含む、光学活性な1,1,3-トリメチル-4-アミノインダンの製造方法。
[14] 酸の酸解離定数(pKa)が2.8未満である、[13]記載の製造方法。
[15] 式(5)で示される光学活性な化合物のエナンチオマー比が、R体/S体で70/30以上である、[12]~[14]のいずれか一項記載の製造方法。
[16] [12]~[15]のいずれか一項記載の製造方法で得た光学活性な1,1,3-トリメチル-4-アミノインダンと式(6):
(式中、R12およびR13は、それぞれ独立して、1つ以上のハロゲン原子で置換されていてもよいC1-C6アルキル基、または水素原子を表し、そして、R14は、ハロゲン原子、ヒドロキシ基、または1つ以上のハロゲン原子で置換されていてもよいC1-C6アルコキシ基を表す。)
で示される化合物とを反応させて、式(7):
(式中、R12、R13および*は、それぞれ上記と同じ意味を表す。)
で表される光学活性な化合物を得る工程をさらに含む、光学活性な化合物の製造方法。
[17] 式(1’):
(式中、R1は、イソプロピル基またはtert-ブチル基を表す。*が付された炭素原子は、不斉炭素原子を表す。)
で示される不斉コバルト錯体。
[18] 式(1’):
(式中、R1は、イソプロピル基またはtert-ブチル基を表す。*が付された炭素原子は、不斉炭素原子を表す)
で示される不斉コバルト錯体とヒドリド還元剤とを反応させて得られるヒドリド錯体。
[19] 式(1’):
(式中、R1は、イソプロピル基またはtert-ブチル基を表す。*が付された炭素原子は、不斉炭素原子を表す)
で示される不斉コバルト錯体とアルキルリチウムとを反応させて得られるアルキル錯体。
これらC1-C10アルキル基が有していてもよい置換基としては、例えば、フェニル基、ナフチル基、4-メチルフェニル基、および4-メトキシフェニル基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリール基;メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブチルオキシ基、tert-ブトキシ基、およびトリフルオロメトキシ基等の、1つ以上のフッ素原子を有していてもよいC1-C10アルコキシ基;ベンジルオキシ基、4-メチルベンジルオキシ基、および4-メトキシベンジルオキシ基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリール基を有するC1-C10アルコキシ基;3-フェノキシベンジルオキシ基等の、1つ以上のC6-C10アリールオキシ基を有するC6-C10アリール基を有するC1-C10アルコキシ基;フェノキシ基、2-メチルフェノキシ基、4-メチルフェノキシ基、および4-メトキシフェノキシ基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリールオキシ基;3-フェノキシフェノキシ基等の、1つ以上のC6-C10のアリールオキシ基を有するC6-C10アリールオキシ基;アセチル基、プロピオニル基、ベンジルカルボニル基、4-メチルベンジルカルボニル基、4-メトキシベンジルカルボニル基、ベンゾイル基、2-メチルベンゾイル基、4-メチルベンゾイル基、および4-メトキシベンゾイル基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10のアリール基を有していてもよいC2-C10アシル基;カルボキシ基;並びにフッ素原子が挙げられる。
1つ以上の置換基を有するC1-C10アルキル基としては、例えば、フルオロメチル基、トリフルオロメチル基、メトキシメチル基、エトキシメチル基、メトキシエチル基、ベンジル基、4-フルオロベンジル基、4-メチルベンジル基、フェノキシメチル基、2-オキソプロピル基、2-オキソブチル基、フェナシル基、および2-カルボキシエチル基が挙げられる。
これらC3-C10シクロアルキル基が有していてもよい置換基としては、例えば、フェニル基、ナフチル基、4-メチルフェニル基、および4-メトキシフェニル基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリール基;メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブチルオキシ基、tert-ブトキシ基、およびトリフルオロメトキシ基等の、1つ以上のフッ素原子を有していてもよいC1-C10アルコキシ基;ベンジルオキシ基、4-メチルベンジルオキシ基、4-メトキシベンジルオキシ基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリール基を有するC1-C10アルコキシ基;3-フェノキシベンジルオキシ基等の、1つ以上のC6-C10アリールオキシ基を有するC6-C10アリール基を有するC1-C10アルコキシ基;フェノキシ基、2-メチルフェノキシ基、4-メチルフェノキシ基、および4-メトキシフェノキシ基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10アリールオキシ基;3-フェノキシフェノキシ基等の、1つ以上のC6-C10のアリールオキシ基を有するC6-C10アリールオキシ基;アセチル基、プロピオニル基、ベンジルカルボニル基、4-メチルベンジルカルボニル基、4-メトキシベンジルカルボニル基、ベンゾイル基、2-メチルベンゾイル基、4-メチルベンゾイル基、および4-メトキシベンゾイル基等の、1つ以上のC1-C10アルキル基またはC1-C10アルコキシ基を有していてもよいC6-C10のアリール基を有していてもよいC2-C10アシル基;カルボキシ基;並びにフッ素原子が挙げられる。
置換基を有するC3-C10シクロアルキル基としては、例えば、フルオロシクロプロピル基、4-トリフルオロシクロヘキシル基、4-メトキシシクロペンチル基、および4-フェニルシクロヘキシル基が挙げられる。
これらC6-C10アリール基が有していてもよい置換基としては、例えば、メチル基、フルオロメチル基、トリフルオロメチル基、メトキシメチル基、エトキシメチル基、およびメトキシエチル基等の、1つ以上のC1-C10アルコキシ基またはフッ素原子を有していてもよいC1-C10アルキル基;メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブチルオキシ基、sec-ブチルオキシ基、tert-ブチルオキシ基、ペンチルオキシ基、フルオロメトキシ基、トリフルオロメトキシ基、メトキシメトキシ基、エトキシメトキシ基、およびメトキシエトキシ基等の、1つ以上のC1-C10アルコキシ基またはフッ素原子を有していてもよいC1-10アルコキシ基;シクロペンチルオキシ基などのC3-C10シクロアルキルオキシ基;並びに、フッ素原子、塩素原子等のハロゲン原子が挙げられる。
1つ以上の置換基を有するC6-C10アリール基としては、例えば、2-メチルフェニル基、4-メチルフェニル基、4-クロロフェニル基および4-メトキシフェニル基が挙げられる。
R1としては、1つ以上の置換基を有していてもよいC1-10アルキル基が好ましく、1つ以上の置換基を有していてもよいC1-C4アルキル基がより好ましい。
R2およびR3としては、それぞれ独立して水素原子、またはC1-C4アルキル基が好ましい。
R4としては、C1-C4アルコキシ基、またはハロゲン原子が好ましい。
nは2または3であることが好ましく、3であることがより好ましい。
Xとしては、塩素原子または臭素原子が好ましい。
R1、R2、R3およびXとして、これらを組み合わせることが好ましい。
前駆体である光学活性なビスオキサゾリニルピリジン誘導体は、たとえば、Tetrahedron Letters,第45巻,第8988頁(2004)のScheme 1等に記載された方法に準じて製造することができる。即ち、2,6-ジカルボキシピリジン誘導体を塩化チオニルと反応させて対応するカルボン酸クロライドとし、これと光学活性なアミノアルコールとを反応させてジアミドとした後、塩化チオニルと反応させてヒドロキシ基を塩素化し、次いでNaOH/メタノール中でオキサゾリン環への閉環反応を行うことにより、光学活性なビスオキサゾリニルピリジン誘導体を製造することができる。
ヒドリド還元剤としては、錯体(1)の二価のコバルト原子を還元して一価のコバルト原子を有するヒドリド錯体を生成させ得る還元剤であればよく、例えば、トリエチル水素化ホウ素リチウム、トリエチル水素化ホウ素ナトリウム、トリエチル水素化ホウ素カリウム、トリメチル水素化ホウ素リチウム、トリメチル水素化ホウ素ナトリウム、トリプロピル水素化ホウ素リチウム、トリプロピル水素化ホウ素ナトリウム、トリブチル水素化ホウ素リチウム、およびトリブチル水素化ホウ素ナトリウム等のトリアルキル水素化ホウ素アルカリ金属塩が挙げられる。
ヒドリド還元剤の使用量は、錯体(1)1モルに対して、通常2モルから20モル、好ましくは4モルから10モルの範囲である。
反応は、不活性ガス雰囲気下で、ヒドリド還元剤に対して不活性な溶媒中で、錯体(1)とヒドリド還元剤とを混合することにより実施される。また、化合物(2)の存在下で実施してもよい。
かかる溶媒としては、例えば、ジエチルエーテル、テトラヒドロフラン、メチルテトラヒドロフラン、1,4-ジオキサン、およびメチルtert-ブチルエーテル等のエーテル溶媒;n-ヘキサン、n-へプタン、およびシクロヘキサン等の脂肪族炭化水素溶媒;トルエン、キシレン、およびクロロベンゼン等の芳香族炭化水素溶媒;ならびに、ジクロロメタン、およびジクロロエタン等のハロゲン化炭化水素溶媒が挙げられ、エーテル溶媒が好ましい。
溶媒の使用量は、錯体(1)の1重量部に対し、通常2重量部から100重量部の範囲である。
反応温度は、通常-70℃から100℃の範囲である。
反応時間は、通常10分から4時間の範囲である。
反応終了後、得られたヒドリド錯体は、単離してもよいが、通常は、単離することなく化合物(2)と水素との反応に用いられる。
アルキルリチウム化合物の使用量は、錯体(1)1モルに対して、通常2モルから20モル、好ましくは3モルから10モルの範囲である。
反応は、不活性ガス雰囲気下で、アルキルリチウム化合物に対して不活性な溶媒中で、錯体(1)とアルキルリチウム化合物とを混合することにより実施される。また、化合物(2)の存在下で実施してもよい。
かかる溶媒としては、例えば、ジエチルエーテル、テトラヒドロフラン、メチルテトラヒドロフラン、1,4-ジオキサン、およびメチルtert-ブチルエーテル等のエーテル溶媒;n-ヘキサン、n-へプタン、およびシクロヘキサン等の脂肪族炭化水素溶媒;トルエン、キシレン、およびクロロベンゼン等の芳香族炭化水素溶媒;ならびに、ジクロロメタン、およびジクロロエタン等のハロゲン化炭化水素溶媒が挙げられ、エーテル溶媒が好ましい。
溶媒の使用量は、錯体(1)の1重量部に対し、通常2重量部から100重量部の範囲である。
反応温度は、通常-70℃から100℃の範囲である。
反応時間は、通常10分から4時間の範囲である。
反応終了後、得られたアルキル錯体は、単離してもよいが、通常は、単離することなく化合物(2)と水素との反応に用いられる。
グリニヤー試薬の使用量は、錯体(1)1モルに対して、通常2モルから20モル、好ましくは3モルから10モルの範囲である。
反応は、不活性ガス雰囲気下で、グニリヤー試薬に対して不活性な溶媒中で、錯体(1)とグリニヤー試薬とを混合することにより実施される。また、化合物(2)の存在下で実施してもよい。
かかる溶媒としては、例えば、ジエチルエーテル、テトラヒドロフラン、メチルテトラヒドロフラン、1,4-ジオキサン、およびメチルtert-ブチルエーテル等のエーテル溶媒;n-ヘキサン、n-へプタン、およびシクロヘキサン等の脂肪族炭化水素溶媒;トルエン、キシレン、およびクロロベンゼン等の芳香族炭化水素溶媒;ならびに、ジクロロメタン、およびジクロロエタン等のハロゲン化炭化水素溶媒が挙げられ、エーテル溶媒が好ましい。
溶媒の使用量は、錯体(1)の1重量部に対し、通常2重量部から100重量部の範囲である。
反応温度は、通常-70℃から100℃の範囲である。
反応時間は、通常10分から4時間の範囲である。
反応終了後、得られたアルキル錯体は、単離してもよいが、通常は、単離することなく化合物(2)と水素との反応に用いられる。
かかる溶媒としては、例えば、ジエチルエーテル、メチルtert-ブチルエーテル、テトラヒドロフラン、1,4-ジオキサンおよびメチルテトラヒドロフラン等のエーテル溶媒;クロロホルムおよびクロロベンゼン等のハロゲン化炭化水素溶媒;トルエン、およびキシレン等の芳香族溶媒;並びに、アセトニトリルおよびプロピオニトリル等のニトリル溶媒が挙げられる。好ましくは、エーテル溶媒であり、特に好ましくは、テトラヒドロフランまたは1,4-ジオキサンである。
溶媒の使用量は特に制限されず、容積効率等を考慮すると、実用的には、化合物(2)1重量部に対して、100重量部以下である。
かかる2価のハロゲン化コバルト塩としては、例えば、CoCl2、CoBr2およびCoI2が挙げられる。好ましくは、CoBr2である。
2価のハロゲン化コバルト塩の使用量は、通常、ヒドリド錯体(1)1モルに対して、2モル以下である。
かかるトリアルキルアミンとしては、例えば、トリメチルアミン、トリエチルアミン、トリプロピルアミン及びトリブチルアミンが挙げられる。好ましくは、トリエチルアミンである。
トリエチルアミンの使用量は、通常、化合物(2)1モルに対して、0.5モル倍以上から3モル倍以下である。
水素の使用量は、化合物(2)1モルに対して、通常1モルから10モルの範囲である。
反応温度は、通常-40℃から100℃の範囲であり、好ましくは-20℃から80℃の範囲である。
酸としては、硫酸が好ましい。硫酸濃度は、通常90重量%から98重量%の範囲であり、収率の点で92重量%から97重量%の範囲であることが好ましい。
光学活性化合物(3)と酸との反応は、有機溶媒の非存在下で実施され、反応温度は、通常20℃から80℃の範囲である。
酸の使用量は、光学活性化合物(3)の1重量部に対して、通常1重量部から10重量部の範囲である。
得られる光学活性化合物(4)としては、例えば、N-アセチル-1,1,3-トリメチル-4-アミノインダン、N-アセチル-7-フルオロ-1,1,3-トリメチル-4-アミノインダン、N-アセチル-7-エトキシ-1,1,3-トリメチル-4-アミノインダン、N-アセチル-1,1-ジメチル-3-エチル-4-アミノインダン、N-アセチル-1,1-ジメチル-3-プロピル-4-アミノインダン、N-アセチル-1,1-ジメチル-3-ブチル-4-アミノインダン、N-アセチル-1,1-ジプロピル-3-メチル-4-アミノインダン、N-エチルカルボニル-1,1,3-トリメチル-4-アミノインダン、N-エチルカルボニル-1,1-ジメチル-3-エチル-4-アミノインダン、N-エチルカルボニル-1,1-ジメチル-3-プロピル-4-アミノインダン、N-エチルカルボニル-1,1-ジメチル-3-ブチル-4-アミノインダン、N-エチルカルボニル-1,1-ジエチル-3-メチル-4-アミノインダン、N-エチルカルボニル-1,1-ジプロピル-3-メチル-4-アミノインダン、N-アセチル-1,1,3,6-テトラメチル-4-アミノインダン、およびN-アセチル-1,1,3,6,7-ペンタメチル-4-アミノインダンが挙げられる。
加水分解反応の反応温度は、通常50℃から110℃の範囲である。
水の使用量は、光学活性化合物(4)1重量部に対して、通常1重量部から10重量部の範囲である。
得られる光学活性化合物(5)としては、例えば、1,1,3-トリメチル-4-アミノインダン、7-フルオロ-1,1,3-トリメチル-4-アミノインダン、7-エトキシ-1,1,3-トリメチル-4-アミノインダン、1,1-ジメチル-3-エチル-4-アミノインダン、1,1-ジメチル-3-プロピル-4-アミノインダン、1,1-ジメチル-3-ブチル-4-アミノインダン、1,1-ジプロピル-3-メチル-4-アミノインダン、1,1-ジエチル-3-メチル-4-アミノインダン、1,1,3,6-テトラメチル-4-アミノインダン、および1,1,3,6,7-ペンタメチル-4-アミノインダンが挙げられる。
得られた反応混合物をアルカリで中和し、トルエン等の水と混和しない有機溶媒を用いて抽出することにより、光学活性化合物(5)を含む溶液が得られる。光学活性化合物(5)のエナンチオマー比(R体/S体またはS体/R体)は、通常60/40から90/10の範囲である。
光学活性な酒石酸は、通常、市販されているものが使用できる。
光学活性な酒石酸の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダン1モル(R体とS体との合計)に対して、通常0.7モルから1.3モル、好ましくは0.8から1.2モルの範囲である。
溶媒の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダン1重量部に対して、通常0.5重量部から10重量部の範囲である。
混合温度は、通常20℃から70℃の範囲である。
混合順序は特に限定されず、光学活性な1,1,3-トリメチル-4-アミノインダンと光学活性な酒石酸と溶媒とを一度に混合してもよいし、光学活性な酒石酸と溶媒との混合物に光学活性な1,1,3-トリメチル-4-アミノインダンを加えてもよいし、光学活性な1,1,3-トリメチル-4-アミノインダンに光学活性な酒石酸と溶媒との混合物を加えてもよいし、光学活性な1,1,3-トリメチル-4-アミノインダンと溶媒との混合物に光学活性な酒石酸を加えてもよい。
アルコール溶媒と水との混合溶媒を用いる場合、光学活性な1,1,3-トリメチル-4-アミノインダンと光学活性な酒石酸とメタノールと水とを一度に混合してもよいし、光学活性な酒石酸とアルコール溶媒と水との混合物に光学活性な1,1,3-トリメチル-4-アミノインダンを加えてもよいし、光学活性な1,1,3-トリメチル-4-アミノインダンに光学活性な酒石酸とアルコール溶媒と水との混合物を加えてもよいし、光学活性な酒石酸とアルコール溶媒と光学活性な1,1,3-トリメチル-4-アミノインダンとの混合物に水を加えてもよいし、光学活性な1,1,3-トリメチル-4-アミノインダンとアルコール溶媒と水との混合物に光学活性な酒石酸を加えてもよい。
これらの混合順序において、後から加える物は、一度に全量を加えてもよいし、数回に分割(例えば、滴下)して加えてもよいし、連続的に加えていってもよい。光学活性な1,1,3-トリメチル-4-アミノインダンと溶媒との混合物に光学活性な酒石酸を加える場合、光学活性な酒石酸は連続的に加えていくことが好ましい。
冷却速度は、通常1℃/時間から10℃/時間の範囲であり、かかる冷却速度で混合物を冷却することにより、高い光学純度の1,1,3-トリメチル-4-アミノインダンと光学活性な酒石酸とを含む結晶が析出させることができる。冷却速度は、好ましくは1℃/時間から8℃/時間の範囲であり、より好ましくは3℃/時間から6℃/時間の範囲である。
こうして得られた結晶とアルカリ金属水酸化物の水溶液とを混合することにより、光学活性な1,1,3-トリメチル-4-アミノインダンと、光学活性な酒石酸のアルカリ金属塩とに分解できる。
アルカリ金属水酸化物としては、水酸化ナトリウムおよび水酸化カリウムが挙げられる。
アルカリ金属水酸化物の使用量は、光学分割に用いた光学活性な酒石酸1モルに対して、アルカリ金属換算で、通常1モルから3モルの範囲である。
アルカリ金属水酸化物の水溶液の混合は、有機溶媒の存在下に実施されてもよい。有機溶媒としては、例えば、トルエン、キシレン、およびエチルベンゼン等の芳香族炭化水素溶媒;モノクロロベンゼン等のハロゲン化芳香族炭化水素溶媒;ヘプタンおよびヘキサン等の脂肪族炭化水素溶媒;シクロペンタンおよびシクロヘキサン等の脂環式炭化水素溶媒;ジエチルエーテルおよびtert-ブチルメチルエーテル等のエーテル溶媒;および、酢酸エチル等のエステル溶媒が挙げられる。
有機溶媒の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダンと光学活性な酒石酸塩とを含む結晶1重量部に対して通常10重量部以下である。
本発明の優先晶析は、溶媒の存在下、光学活性な1,1,3-トリメチル-4-アミノインダンとアキラルな酸とを混合してそれらの酸塩を析出させる第1工程、および、第1工程で得られた酸塩と塩基とを混合して光学活性な1,1,3-トリメチル-4-アミノインダンを得る第2工程を含む。
先ず、光学活性な1,1,3-トリメチル-4-アミノインダンを含む溶液と酸とを混合して酸塩を析出させる第1工程について説明する。
かかる塩を形成するためには、酸解離定数(pKa)が2.8未満である酸が、通常、用いられる。
ここで、酸解離定数とは、酸から水素イオンが放出される酸解離反応を考えた場合の酸の電離平衡の平衡定数(Ka)、またはその負の常用対数である解離定数(pKa)によって表される、酸の強さを示す1つの指標である。平衡定数Ka値が大きいほど、あるいは解離定数pKa値が小さいほど、その酸は強い酸であることを意味する。
本発明における酸解離定数(pKa)として、Chemical Abstracts Serviceが提供するデータベースであるSciFinderに計算値(Advanced Chemistry Development (ACD/Labs) Software V11.02を用いて算出された値)が収録されている場合は、その値を採用する。かかる値は、例えば、化学情報協会のホームページ(https://www.jaici.or.jp/SCIFINDER/)から検索可能である。計算値がSciFinderに収録されていない酸についてはChemical Bookのホームページ(https://www.chemicalbook.com/)に掲載されているデータを採用し、かかるホームページにも掲載されていない酸についてはApplied Catalysis A: General 492 (2015) 252-261に記載されている値を採用し、更にかかる雑誌にも掲載されていない場合は、Advanced Chemistry Development (ACD/Labs) Software V11.02を用いて計算した値を採用する。
硫酸水素塩としては、硫酸水素ナトリウム、硫酸水素リチウム、および硫酸水素カリウム等の硫酸水素アルカリ金属塩が挙げられる。
有機スルホン酸としては、メタンスルホン酸、エタンスルホン酸、ベンゼンスルホン酸、p-トルエンスルホン酸、カンファースルホン酸、およびタウリン等が挙げられる。
ハロゲン化水素酸としては、塩酸、臭化水素酸、およびヨウ化水素酸が挙げられる。
有機リン酸類としては、リン酸二水素フェニル、リン酸二水素エチル、フェニルホスホン酸、およびメチルホスホン酸等が挙げられる。
カルボン酸としては、シュウ酸、トリクロロ酢酸、トリフルオロ酢酸、ジクロロ酢酸、モノクロロ酢酸、モノブロモ酢酸、2-ニトロ安息香酸、およびペンタフルオロフェニルカルボン酸等が挙げられる。
これらの中でも、硫酸、硫酸水素塩、スルファミン酸、有機スルホン酸、ハロゲン化水素酸、リン酸、有機リン酸類、硝酸、テトラフルオロホウ酸、およびカルボン酸からなる群から選ばれる1以上の酸を用いることがより好ましい。硫酸、硫酸水素ナトリウム、硫酸水素カリウム、スルファミン酸、メタンスルホン酸、p-トルエンスルホン酸、ベンゼンスルホン酸、塩酸、臭化水素酸、リン酸、フェニルリン酸、リン酸二水素フェニル、硝酸、テトラフルオロホウ酸、シュウ酸、トリフルオロ酢酸、トリクロロ酢酸、2-ニトロ安息香酸、クロロ酢酸、およびブロモ酢酸からなる群から選ばれる1以上の酸を用いることが、さらに好ましい。硫酸、硫酸水素ナトリウム、硫酸水素カリウム、スルファミン酸、メタンスルホン酸、p-トルエンスルホン酸、ベンゼンスルホン酸、塩酸、臭化水素酸、リン酸、フェニルリン酸、リン酸二水素フェニル、硝酸、テトラフルオロホウ酸、シュウ酸、トリフルオロ酢酸、トリクロロ酢酸、および2-ニトロ安息香酸からなる群から選ばれる1以上の酸を用いることが、さらにより好ましい。
酸の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダンの1モルに対して、硫酸以外の酸の場合は、通常0.7モルから1.5モル、好ましくは0.7モルから1.0モルの範囲であり、硫酸の場合は、通常0.35モルから0.5モル、好ましくは0.35モルから0.45モルの範囲である。
溶媒の使用量は、1,1,3-トリメチル-4-アミノインダン1重量部に対して、通常0.5重量部から20重量部、好ましくは、1.0重量部から10重量部の範囲である。
混合順序は、1,1,3-トリメチル-4-アミノインダンと酸と溶媒とを、一度に混合してもよいし、酸と溶媒とを混合した後、得られる混合物に、1,1,3-トリメチル-4-アミノインダンを加えてもよい。1,1,3-トリメチル-4-アミノインダンに、酸と溶媒との混合物を加えてもよい。また、1,1,3-トリメチル-4-アミノインダンと溶媒とを混合した後、得られる混合物に、酸、または酸と溶媒との混合物を加えてもよい。好ましくは、1,1,3-トリメチル-4-アミノインダンと溶媒とを混合した後、得られる混合物に、酸、または酸と溶媒との混合物を加える方法が好ましい。また、混合後、冷却しても結晶が析出しない場合は、溶媒を一部留去することで結晶を析出させてもよい。
冷却速度は、特に制限されないが、通常1℃/時間から100℃/時間程度の範囲である。
塩基としては、無機塩基および有機塩基を挙げられる。
無機塩基としては、アルカリ金属水酸化物、アルカリ土類金属水酸化物、炭酸アルカリ金属、炭酸アルカリ土類金属、およびリン酸アルカリ金属等が挙げられる。
アルカリ金属水酸化物としては、水酸化ナトリウムおよび水酸化カリウムが挙げられる。
アルカリ土類金属水酸化物としては、水酸化カルシウムおよび水酸化マグネシウムが挙げられる。
炭酸アルカリ金属としては、炭酸カリウムおよび炭酸ナトリウムが挙げられる。
炭酸アルカリ土類金属としては、炭酸カルシウムおよび炭酸マグネシウムが挙げられる。
リン酸アルカリ金属としては、リン酸三ナトリウムおよびリン酸三カリウムが挙げられる。
好ましくは、アルカリ金属水酸化物である。
有機塩基としては、第3級アミン、第2級アミン、および第1級アミンが挙げられる。
第3級アミンとしては、トリエチルアミン、トリプロピルアミン、およびトリブチルアミン等が挙げられる。
第2級アミンとしては、ジエチルアミン、ジプロピルアミン、およびジブチルアミン等が挙げられる。
第1級アミンとしては、ブチルアミンおよびベンジルアミン等が挙げられる。
好ましくは、第3級アミンである。
塩基の量は、第1工程で用いた酸1モルに対して、塩基換算で、通常0.5モルから3モルの範囲である。混合温度は、通常10℃から80℃の範囲である。
また、光学活性な1,1,3-トリメチル-4-アミノインダンを後述するアミド化反応Dに用いる場合は、酸塩のまま式(1-3)で示される化合物との反応に供することにより、まずは酸塩が反応系中の塩基により中和されて光学活性な1,1,3-トリメチル-4-アミノインダンを与え、これと式(1-3)で示される化合物とが反応することにより、本発明の第2工程とアミド化反応Dとを連続的に行うことができる。
R13は、メチル基、モノフルオロメチル基、ジフルオロメチル基又はトリフルオロメチル基が好ましく、ジフルオロメチル基がより好ましい。
R14は、塩素原子、エトキシ基およびヒドロキシ基が好ましく、塩素原子がより好ましい。
化合物(6)としては、1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸エチル、1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸、および1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸クロライド等が挙げられる。
アミド化反応Aは、光学活性な1,1,3-トリメチル-4-アミノインダンと、上記式(6)におけるR14がヒドロキシ基である化合物(本明細書中、以下、「化合物(6-1)」と記載することがある)とを、脱水縮合剤の存在下に反応させて光学活性化合物(7)を得る反応である。
(式中、R12およびR13は前記と同じ意味を表す。)
脱水縮合剤の使用量は、化合物(6-1)の1モルに対して、通常1モルから5モルの範囲である。
光学活性な1,1,3-トリメチル-4-アミノインダンの使用量は、化合物(6-1)の1モルに対して、通常0.5モルから3モルの範囲である。
アミド化反応Bは、光学活性な1,1,3-トリメチル-4-アミノインダンと化合物(6-1)とを、ルイス酸の存在下に反応させて光学活性化合物(7)を得る工程である。
ルイス酸の使用量は、化合物(6-1)の1モルに対して、通常0.001モルから3モルの範囲である。
光学活性な1,1,3-トリメチル-4-アミノインダンの使用量は、化合物(6-1)1モルに対して、通常0.5モルから3モルの範囲である。
反応終了後、アミド化反応Aと同様の処理を行うことで光学活性化合物(7)を取り出すことができる。
アミド化反応Cは、光学活性な1,1,3-トリメチル-4-アミノインダンと、上記式(6)におけるR14が1つ以上のハロゲン原子で置換されていてもよいC1-C10アルコキシ基である化合物(本明細書中、以下、「化合物(6-2)」と記載することがある)とを、ルイス酸またはルイス塩基の存在下に反応させて光学活性化合物(7)を得る工程である。
(式中、R12およびR13は前記と同じ意味を表し、R14’は、1つ以上のハロゲン原子で置換されていてもよいC1-C10アルコキシ基を表す。)
ルイス酸の使用量は、化合物(6-2)の1モルに対して、通常0.01モルから3モルの範囲である。
光学活性な1,1,3-トリメチル-4-アミノインダンの使用量は、化合物(6-2)1モルに対して、通常0.5モルから3モルの範囲である。
ルイス塩基の使用量は、化合物(6-2)の1モルに対して、通常0.01モルから3モルの範囲である。
光学活性な1,1,3-トリメチル-4-アミノインダンの使用量は、化合物(6-2)1モルに対して、通常0.5モルから3モルの範囲である。
反応終了後、アミド化反応Aと同様の処理を行うことで光学活性化合物(7)を取り出すことができる。
アミド化反応Dは、光学活性な1,1,3-トリメチル-4-アミノインダンと上記式(6)におけるR14がハロゲン原子である化合物(本明細書中、以下、「化合物(6-3)」と記載することがある)とを、塩基の存在下に反応させて光学活性化合物(7)を得る工程である。
(式中、R12およびR13は前記と同じ意味を表し、R14’’はハロゲン原子を表す。)
塩基の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダンの1モルに対して、通常、触媒量から5モル、好ましくは1モルから3モルの範囲である。
化合物(6-3)の使用量は、光学活性な1,1,3-トリメチル-4-アミノインダンの1モルに対して、通常0.5モルから1.5モル、好ましくは0.8モルから1.3モルであり、より好ましくは1.0モルから1.2モルの範囲である。
反応終了後、アミド化反応Aと同様の処理を行うことで光学活性化合物(7)を取り出すことができる。
取り出した光学活性化合物(7)は、カラムクロマトグラフィー、および再結晶等によりさらに精製することもでき、精製することが好ましい。
精製方法としては、光学活性化合物(7)を溶媒に溶解させて溶液を調整し、該溶液を用いて再結晶を行う方法が好ましい。再結晶の際に種晶を用いてもよい。
かかる溶媒としては、ペンタン、ヘキサン、ヘプタン、オクタンおよびシクロヘキサン等の脂肪族炭化水素溶媒;トルエン、キシレンおよびエチルベンゼン等の芳香族炭化水素溶媒;ジクロロメタン、クロロホルム、1,2-ジクロロエタンおよび四塩化炭素等のハロゲン化脂肪族炭化水素溶媒;クロロベンゼン、ジクロロベンゼンおよびトリクロロベンゼン等のハロゲン化芳香族炭化水素溶媒;ジエチルエーテル、ジイソプロピルエーテル、tert-ブチルメチルエーテル、シクロヘキシルメチルエーテル、エチレングリコールジメチルエーテル、テトラヒドロフランおよびジオキサン等のエーテル溶媒;酢酸エチルおよび酢酸ブチル等のエステル溶媒;アセトニトリル等のニトリル溶媒;メタノール、エタノールおよび2-プロパノール等のアルコール溶媒;およびこれらの2つ以上の混合溶液が挙げられ、脂肪族炭化水素溶媒、芳香族炭化水素溶媒、ハロゲン化芳香族炭化水素溶媒およびエステル溶媒が好ましく、トルエン、キシレン、エチルベンゼン、ヘキサン、ヘプタンおよび酢酸エチルがより好ましい。
実施例において、R体/S体の比率は、キラルカラムを用いた高速液体クロマトグラフィー(面積百分率法)を用いて分析した。1,1,3-トリメチル-4-アミノインダンおよび(R)-(-)-N-(1,1,3-トリメチルインダン-4-イル)-1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸アミドのそれぞれの含量は、液体クロマトグラフィー(内部標準法)を用いて分析した。
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトの合成>
窒素置換した還流冷却管を付した100mLフラスコに、2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン2.37gとテトラヒドロフラン43gを仕込み、25℃で攪拌して2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジンが溶解したことを確認した。得られた溶液に、25℃で、臭化コバルト(II)1.31gを加えたのち、混合物を昇温して、2時間加熱還流した。室温まで冷却した後、得られた反応混合物から溶媒を留去し、8gのテトラヒドロフランを加え、スラリー状にしたのち、さらにメチル-t-ブチルエーテル185gを加え、混合物を1時間加熱還流した。室温まで冷却して結晶を析出させ、得られた結晶をろ過し、結晶をメチル-t-ブチルエーテル150gで洗浄後、乾燥し、青緑色粉末3.41gを得た。 得られた粉末は、EI-MSより、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトであることを確認した。収率:88%
EI-MS=546、548、550
<ジブロモ[2,6-ビス[4-(S)-イソプロピル-2-オキサゾリル]ピリジン]コバルトの合成>
実施例1において、2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン2.37gに代えて、2,6-ビス[4-(S)-イソプロピル-2-オキサゾリル]ピリジン2.16gを用いる以外は、実施例1と同様に実施して、青緑色粉末3.17gを得た。収率:85%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]-4-メトキシピリジン]コバルトの合成>
実施例1において、2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン2.37gに代えて、2,6-ビス[4-(S)-イソブチル-2-オキサゾリル]-4-メトキシピリジン2.59gを用いる以外は、実施例1と同様に実施して、青緑色粉末3.54gを得た。収率:85%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト88mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン3.44gおよびテトラヒドロフラン11.5gを仕込んだ。窒素置換後、35℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.64mL加え、水素置換し、水素で0.95MPaまで加圧し、混合物を35℃で1時間加圧下に攪拌した。反応後、15℃まで冷却した後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1,2,3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=82.5%、収率=99%
<ジクロロ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジクロロ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト74mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン3.44gおよびテトラヒドロフラン11.5gを仕込んだ。窒素置換後、35℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.64mL加え、水素置換し、水素で0.95MPaまで加圧し、混合物を35℃で1時間加圧下に攪拌した。反応後、15℃まで冷却した後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1,2,3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=70%、収率=99%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト44mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン6.89g、臭化コバルト(II)17.5mgおよびテトラヒドロフラン11.5gを仕込んだ。窒素置換後、混合物を40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.8mL加え、水素置換し、水素で0.95MPaまで加圧し、混合物を40℃で2時間加圧下に攪拌した。反応後、混合物を15℃まで冷却した後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1,2,3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=75.0%、収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
実施例6において臭化コバルト(II)を加えないことを除いては、実施例6の方法に準じて、反応を実施した。反応後、混合物を15℃まで冷却した後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2,3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=58.0%、収率=85%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト88mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン6.89g、臭化コバルト(II)35mgおよびテトラヒドロフラン11.5gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を1.6mL加え、水素置換し、水素で0.95MPaまで加圧し、混合物を40℃で2時間加圧下に攪拌した。反応後、混合物を15℃まで冷却した後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=72.5%、収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト44mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン6.89g、トリエチルアミン3.85gおよび1,4-ジオキサン8.2gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.64mL加え、40℃で1時間保温攪拌した。1時間後、反応液を15℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を15℃で5時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=90.0%、収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト22mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン3.44g、トリエチルアミン1.93gおよび1,4-ジオキサン4.1gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.4mL加え、40℃で1時間保温攪拌した。1時間後、反応液を25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で3時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=86.5%、収率=99%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト88mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン13.8g、臭化コバルト(II)35mgおよび1,4-ジオキサン16.5gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を1.2mL加え、40℃で1時間保温攪拌した。1時間後、反応液を25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で4時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=86.0%、収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト44mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン6.89g、1,4-ジオキサン8.2gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.6mL加え、40℃で1時間保温攪拌した。1時間後、25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で4時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=83.6%、収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト44mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-6-フルオロ-1-キノリン7.5g、1,4-ジオキサン8.2gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.6mL加え、40℃で1時間保温攪拌した。1時間後、25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で4時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-6-フルオロ-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=84%、収率=91%
<ジブロモ[2,6-ビス[4-(S)-イソプロピル-2-オキサゾリル]ピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、実施例2で調製したジブロモ[2,6-ビス[4-(S)-イソプロピル-2-オキサゾリル]ピリジン]コバルト52mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン4.31g、トリエチルアミン2.6gおよび1,4-ジオキサン10.1gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/トルエン溶液を0.8mL加え、40℃で1時間保温攪拌した。1時間後、25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で3時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=66.3%、収率=65%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]-4-メトキシピリジン]コバルトのヒドリド還元錯体による不斉水素化反応>
ガラス内筒管を付した100mLオートクレーブに、実施例3で調製したジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]-4-4メトキシピリジン]コバルト58mg、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン4.31g、トリエチルアミン2.6gおよび1,4-ジオキサン10.1gを仕込んだ。窒素置換後、40℃に昇温し、得られた混合物に、1Mのトリエチル水素化ホウ素ナトリウム/テトラヒドロフラン溶液を0.8mL加え、40℃で1時間保温攪拌した。1時間後、25℃まで冷却後、水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で3時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=78.6%、
収率=100%
<ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルトのメチル還元錯体による不斉水素化反応>
窒素雰囲気のシュレンク管に、ジブロモ[2,6-ビス[4-(S)-t-ブチル-2-オキサゾリル]ピリジン]コバルト219mg、1,4-ジオキサン2g、トルエン2gを加え、-40℃に冷却した。この混合液に、1.1Mのメチルリチウム/ジエチルエーテル溶液を2ml加え、そのまま室温になるまで3時間攪拌を継続し、メチル錯体を調製した。
ガラス内筒管を付した100mLオートクレーブに、1-アセチル-1,2-ジヒドロ-2,2,4-トリメチル-1-キノリン8.61g、1,4-ジオキサン10g、トリエチルアミン4.9gを仕込んだ。窒素置換後、25℃で、得られた混合物に、上記シュレンク管で調製したメチル錯体液を全量添加した。水素置換し、水素で0.95MPaまで加圧し、混合物を25℃で4時間加圧下に攪拌した。反応後、窒素置換し、得られた反応混合物のR体比と、1-アセチル-2,2,4-トリメチル-1、2、3,4-テトラヒドロキノリンの収率を、高速液体クロマトグラフィーを用いて分析した。R体比=54.6%、収率=32%
<光学活性な1,1,3-トリメチル-4-アミノインダンの合成>
窒素置換した300mLフラスコに、実施例4または6と同様にして得たR体比が77.7%の1-アセチル-2,2,4-トリメチル-1,2,3,4-テトラヒドロキノリンのテトラヒドロフラン溶液50gを仕込み、テトラヒドロフランを留去した。濃縮液13.3g(含量85%)が残存したフラスコを窒素置換した後に、室温で98%硫酸22.7gおよび水260mgを仕込み、混合物を45℃で6時間加熱攪拌した。反応後、水23gを加え、混合物をさらに110℃で2時間加熱攪拌した。反応終了後、反応液に、27%水酸化ナトリウム水溶液85gを加え、トルエン50gで2回抽出した。トルエン層を合一し、水10gで1回洗浄した後、トルエンを留去した。得られた濃縮液は、光学活性な1、1,3-トリメチル-4-アミノインダンであり、9.6gを得た。液体クロマトグラフィーによる内部標準物質法含量分析法と、光学純度分析を行い、含量と光学純度を求めた。含量90%、光学異性体比 R:S=78.1:21.9%、収率=95%
<d-酒石酸を用いる1,1,3-トリメチル-4-アミノインダンの光学分割>
窒素置換した300mLフラスコに、実施例17で得た1,1,3-トリメチル-4-アミノインダン(R体/S体=78/22)9.6gおよびメタノール36gを仕込み、混合物を60℃に昇温した。d-酒石酸7.4gを水20gに溶解して得られた溶液を、60℃で、30分かけて滴下した。反応混合物を38℃まで冷却後、(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸塩20mgを加えたところ、結晶が析出したので、混合物を10℃まで3時間冷却した。この反応液をヌッチェで減圧濾過を行い、更にヌッチェ上で減圧下、トルエン10gで2回結晶を洗浄、脱液した。この結晶を乾燥して、(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸のメタノール溶媒和物塩を11.4g得た。液体クロマトグラフィーによる光学純度分析を行い、(R)-1,1,3-トリメチル-4-アミノインダンの光学純度を求めた。光学異性体比 R:S=98.1:1.9、収率=65%
<光学活性な1,1,3-トリメチル-4-アミノインダンの合成>
窒素置換した300mLフラスコに、実施例4または6と同様にして得た1-アセチル-2,2,4-トリメチル-1,2、3,4-テトラヒドロキノリン(R体/S体=80.7/19.3)のテトラヒドロフラン溶液53gを仕込み、テトラヒドロフランを留去した。濃縮液15.8g(含量85%)が残存したフラスコを窒素置換した後に、室温で98%硫酸26.9gおよび水180mgを仕込み、混合物を45℃で7時間加熱攪拌した。反応後、水27.3gを加え、混合物をさらに110℃で2時間加熱攪拌した。反応終了後、反応液に、27%水酸化ナトリウム水溶液100gを加え、トルエン60gで2回抽出した。トルエン層を合一し、水12gで1回洗浄した後、トルエンを留去した。得られた濃縮液は、光学活性な1,1,3-トリメチル-4-アミノインダンであり、12.1gを得た。液体クロマトグラフィーによる内部標準物質法含量分析法と、光学純度分析をおこない、含量と光学純度を求めた。含量90%、光学異性体比 R:S=80.7:19.3、収率=98%
<d-酒石酸を用いる1,1,3-トリメチル-4-アミノインダンの光学分割>
窒素置換した300mLフラスコに、実施例19で得た1,1,3-トリメチル-4-アミノインダン(R体/S体=80.7/19.3)12gおよびメタノール46gを仕込み、混合物を60℃に昇温した。d-酒石酸9.8gを水23gに溶解して得られた溶液を、60℃で、30分かけて滴下した。反応混合物を40℃まで冷却後、(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸塩20mgを加えたところ、結晶が析出したので、混合物を10℃まで3時間で冷却した。この反応液をヌッチェで減圧濾過を行い、更にヌッチェ上で減圧下、トルエン10gで2回結晶を洗浄、脱液した。この結晶を乾燥して、(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸のメタノール溶媒和物塩を12.5g得た。液体クロマトグラフィーによる光学純度分析を行い、光学純度を求めた。光学異性体比 R:S=98.1:1.9、収率=70.6%
<硫酸水素ナトリウム(pKa=1.99)を用いる優先晶析の第1工程>
窒素置換した300mLフラスコに1,1,3-トリメチル-4-アミノインダン(R体/S体=83/17)17.5gおよびメタノール60gを仕込み、混合物を60℃に昇温した。硫酸水素ナトリウム・1水和物9.6gを水15gに溶解して得られた溶液を、60℃で、30分かけて滴下したところ、結晶が析出した。反応液を60℃で3時間保温後、室温まで3時間冷却し、さらに10℃まで1時間冷却した。この反応液をヌッチェで減圧濾過を行い、更にヌッチェ上で減圧下、トルエン15gで2回結晶を洗浄、脱液した。この結晶を乾燥して、(R)-1,1,3-トリメチル-4-アミノインダン・硫酸水素ナトリウム塩を19.3g得た。液体クロマトグラフィーによる光学純度分析を行い、光学純度を求めた。
光学異性体比 R:S=96.4:3.6、収率=66%
<優先晶析の第2工程>
窒素置換した100mLフラスコに、実施例21で得た(R)-1,1,3-トリメチル-4-アミノインダン・硫酸水素ナトリウム塩19g、27%水酸化ナトリウム水溶液14.2gおよびトルエン40gを仕込み、混合物を室温で30分攪拌した。トルエン層を、水5gで1回洗浄したのち、トルエンを留去することで(R)-1、1,3-トリメチル-4-アミノインダン11.2gを得た。液体クロマトグラフィーによる内部標準物質法含量分析法と、光学純度分析を行い、含量と光学純度を求めた。
光学異性体比 R:S=96.4:3.6、含量98%、収率=98%
<硫酸水素ナトリウム(pKa=1.99)を用いる優先晶析の第1工程>
窒素置換した300mLフラスコに1,1,3-トリメチル-4-アミノインダン(R体/S体=83/17)17.5gおよびメタノール60gを仕込み、混合物を60℃に昇温した。硫酸水素ナトリウム・1水和物9.3gを水20gに溶解して得られた溶液を、60℃で、30分かけて滴下したところ、結晶が析出した。反応液を70℃で3時間保温後、室温まで3時間冷却し、さらに10℃まで1時間冷却した。この反応液をヌッチェで減圧濾過を行い、更にヌッチェ上で減圧下、トルエン15gで2回結晶を洗浄、脱液した。この結晶を乾燥して、(R)-1,1,3-トリメチル-4-アミノインダン・硫酸水素ナトリウム塩を19.6g得た。液体クロマトグラフィーによる光学純度分析を行い、光学純度を求めた。
光学異性体比 R:S=96.8:3.2、収率=66.5%
<硫酸水素ナトリウム(pKa=1.99)を用いる優先晶析の第1工程>
窒素置換した300mLフラスコに1,1,3-トリメチル-4-アミノインダン(R体/S体=90/10)17.5gおよびメタノール60gを仕込み、混合物を60℃に昇温した。硫酸水素ナトリウム・1水和物11.5gを水18gに溶解して得られた溶液を、60℃で、30分かけて滴下したところ、結晶が析出した。反応液を60℃で2時間保温後、室温まで3時間冷却し、さらに10℃まで1時間冷却した。この反応液をヌッチェで減圧濾過を行い、更にヌッチェ上で減圧下、トルエン15gで2回結晶を洗浄、脱液した。この結晶を乾燥して、(R)-1,1,3-トリメチル-4-アミノインダン・硫酸水素ナトリウム塩を23.5g得た。液体クロマトグラフィーによる光学純度分析を行い、光学純度を求めた。
光学異性体比 R:S=98.4:1.6、収率=80%
<(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸メタノール溶媒和物塩の分解による(R)-1,1,3-トリメチル-4-アミノインダン合成>
窒素置換した100mLフラスコに、実施例17で得た(R)-1,1,3-トリメチル-4-アミノインダン・d-酒石酸のメタノール溶媒和物塩5g、27%水酸化ナトリウム水溶液5.2gおよびトルエン10gを仕込み、混合物を室温で30分攪拌した。トルエン層を、水5gで1回洗浄したのち、トルエンを留去することで(R)-1,1,3-トリメチル-4-アミノインダン2.4gを得た。液体クロマトグラフィーによる内部標準物質法含量分析法と、光学純度分析を行い、含量と光学純度を求めた。
光学異性体比 R:S=98.1:1.9、含量98%、収率=98%
<アミド化反応D>
窒素雰囲気下、室温で、1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸14.0部とキシレン35.1部とを混合した。得られた混合物を100℃に加熱した。得られた混合物に塩化チオニル11.2部を5時間かけて滴下した。得られた混合物を100℃で15時間攪拌した後、40℃まで冷却した。得られた反応混合物から、減圧条件下で、塩化チオニルおよびキシレンを留去して、褐色の1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸クロライドを得た。
(R)-1,1,3-トリメチル-4-アミノインダン14.6部、トリエチルアミン9.2部およびキシレン38.1部を混合して、溶液を調整した。得られた溶液に、前記で得られた1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸クロライドをキシレン13.2部に溶解させた溶液を、45℃~50℃で、2時間かけて滴下した。得られた混合物を、45℃~50℃で15時間攪拌した。得られた反応混合物と20%水酸化ナトリウム水溶液とを混合した後、有機層を分離した。得られた有機層を、水、18%塩酸、水、1%水酸化ナトリウム水溶液および水で順次洗浄した後、減圧条件下で濃縮して、(R)-(-)-N-(1,1,3-トリメチルインダン-4-イル)-1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸アミド27.5部を得た。
実施例27
<アミド化反応D>
窒素雰囲気下、室温で、1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸1.8gとトルエン10gとを混合した。得られた混合物を100℃に加熱した。得られた混合物に、ジメチルホルムアミドを30mg添加後、塩化チオニル1.57gをトルエン5gに溶解した混合液を30分かけて滴下した。得られた混合物を100℃で2時間攪拌した後、40℃まで冷却した。得られた反応混合物から、減圧条件下で、塩化チオニルおよびトルエンを留去して、褐色の1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸クロライドを得た。
この褐色の1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸クロライド液全量、実施例23で得た(R)-1,1,3-トリメチル-4-アミノインダン・硫酸水素ナトリウム塩3g、トルエン10gを混合し、50℃に加温した。この溶液に、トリエチルアミン2.26gとトルエン5gの混合液を、30分で滴下し、2時間保温攪拌した。得られた反応混合物と水を混合した後、有機層を分離した。得られた有機層を、水で3回洗浄した後、減圧条件下で濃縮して、(R)-(-)-N-(1,1,3-トリメチルインダン-4-イル)-1-メチル-3-ジフルオロメチルピラゾール-4-カルボン酸アミド3.3gを得た。
Claims (19)
- 不斉コバルト錯体の存在下、式(2):
(式中、R5は、水素原子、または1つ以上の置換基を有していてもよいC1-C6アルキル基を表し、R6及びR7は、それぞれ独立して、水素原子、またはC1-C6アルキル基を表し、R8は、C1-C6アルキル基を表し、そしてR9、R10およびR11は、それぞれ独立して、水素原子、ハロゲン原子、アミノ基、ヒドロキシ基、1つ以上の置換基を有していてもよいC1-C6アルキル基、1つ以上の置換基を有していてもよいC1-C6アルコキシ基、1つ以上の置換基を有していてもよいC2-C7アルキルカルボニル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表す。)
で示される化合物と水素とを反応させる、式(3):
(式中、R5、R6、R7、R8、R9、R10およびR11は、それぞれ上記と同じ意味を表す。*が付された炭素原子は、不斉炭素原子を表す。)
で示される光学活性な化合物の製造方法。 - 請求項1に記載の不斉コバルト錯体が、式(1):
(式中、R1は各々独立して、1つ以上の置換基を有していてもよいC1-C10アルキル基、1つ以上の置換基を有していてもよいC3-C10シクロアルキル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表す。R2およびR3は、それぞれ独立して、水素原子、1つ以上の置換基を有していてもよいC1-C10アルキル基、または1つ以上の置換基を有していてもよいC6-C10アリール基を表すか、または、R2とR3とが互いに結合して、それらが結合する炭素原子とともに環を形成している。R4は、1つ以上の置換基を有していてもよいC1-C10アルキル基、1つ以上の置換基を有していてもよいC1-C10アルコキシ基、1つ以上の置換基を有していてもよいC1-C10アルキルチオ基、1つ以上の置換基を有していてもよいC2-C11アルコキシカルボニル基、1つ以上の置換基を有していてもよいC2-C11アルキルカルボニル基、1つ以上の置換基を有していてもよいC6-C10アリール基、ハロゲン原子、C1-C10アルキル化でモノもしくはジアルキル化されていてもよいアミノ基、ニトロ基、ヒドロキシ基、スルホ基、C1-C10アルキルスルホニル基、C6-C10アリールスルホニル基、またはハロスルホニル基を表す。nは0、1、2または3を表す。nが0または1である場合、複数のR4は互いに同一であっても相異なっていてもよい。Xは、塩素原子、臭素原子またはヨウ素原子を表す。そして、*が付された炭素原子は、不斉炭素原子を表す。)
で示される不斉コバルト錯体と、還元剤を反応させて得られる1価のコバルト錯体である、請求項1記載の製造方法。 - 還元剤が、ヒドリド還元剤で、1価のコバルト錯体がヒドリド錯体である、請求項2記載の製造方法。
- ヒドリド還元剤が、トリアルキル水素化ホウ素アルカリ金属塩である、請求項3記載の製造方法。
- さらに、2価のハロゲン化コバルト塩の存在下で反応を実施する、請求項3または請求項4記載の製造方法。
- ヒドリド錯体1モルに対し、2価のハロゲン化コバルト塩の使用量が2モル以下である、請求項5記載の製造方法。
- さらに、トリアルキルアミンの存在下で反応を実施する、請求項3または請求項4記載の製造方法。
- 式(2)で表される化合物1モルに対し、トリアルキルアミンの使用量が0.5モルから3モルの範囲である、請求項7記載の製造方法。
- 還元剤が、アルキルリチウムで、1価のコバルト錯体がアルキル錯体である、請求項2記載の製造方法。
- 式(5)におけるR6、R7およびR8がメチル基であり、そして、R9、R10およびR11が水素原子である、請求項10記載の製造方法。
- 請求項11で得た式(5)で示される光学活性な化合物を溶媒に溶解させた後、光学活性な酒石酸を用いて光学分割する工程を含む、光学活性な1,1,3-トリメチル-4-アミノインダンの製造方法。
- 請求項12で得た式(5)で示される光学活性な化合物を溶媒に溶解させた後、酸を加えて優先晶析させる工程を含む、光学活性な1,1,3-トリメチル-4-アミノインダンの製造方法。
- 酸の酸解離定数(pKa)が2.8未満である、請求項13記載の製造方法。
- 式(5)で示される光学活性な化合物のエナンチオマー比が、R体/S体で70/30以上である、請求項12~請求項14のいずれか一項記載の製造方法。
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112022026601A BR112022026601A2 (pt) | 2020-07-17 | 2021-07-06 | Processos para preparação de um composto opticamente ativo, incluindo 1,1,3-trimetil-4-aminoindano, e complexos de cobalto assimétrico, de hidreto e de alquila |
CN202180049266.3A CN115836041A (zh) | 2020-07-17 | 2021-07-06 | 光学活性的化合物的制造方法 |
EP21842357.2A EP4186882A1 (en) | 2020-07-17 | 2021-07-06 | Method for producing optically active compound |
JP2022536280A JPWO2022014414A1 (ja) | 2020-07-17 | 2021-07-06 | |
CA3186051A CA3186051A1 (en) | 2020-07-17 | 2021-07-06 | Method for producing optically active compound |
AU2021308138A AU2021308138A1 (en) | 2020-07-17 | 2021-07-06 | Method for producing optically active compound |
KR1020237003992A KR20230041010A (ko) | 2020-07-17 | 2021-07-06 | 광학 활성인 화합물의 제조 방법 |
US18/005,161 US20230257408A1 (en) | 2020-07-17 | 2021-07-06 | Method for producing optically active compound |
IL299590A IL299590A (en) | 2020-07-17 | 2021-07-06 | A method for producing an optically active compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-122762 | 2020-07-17 | ||
JP2020122762 | 2020-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022014414A1 true WO2022014414A1 (ja) | 2022-01-20 |
Family
ID=79554611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/025489 WO2022014414A1 (ja) | 2020-07-17 | 2021-07-06 | 光学活性な化合物の製造方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230257408A1 (ja) |
EP (1) | EP4186882A1 (ja) |
JP (1) | JPWO2022014414A1 (ja) |
KR (1) | KR20230041010A (ja) |
CN (1) | CN115836041A (ja) |
AU (1) | AU2021308138A1 (ja) |
BR (1) | BR112022026601A2 (ja) |
CA (1) | CA3186051A1 (ja) |
IL (1) | IL299590A (ja) |
WO (1) | WO2022014414A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114773263A (zh) * | 2022-05-16 | 2022-07-22 | 江苏百康德医药科技有限公司 | (r)-2,2,4-三甲基-1,2,3,4-四氢喹啉的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07215921A (ja) | 1993-10-22 | 1995-08-15 | Shell Internatl Res Maatschappij Bv | 有害生物防除剤および中間体の製造方法 |
WO2011162397A1 (en) | 2010-06-24 | 2011-12-29 | Sumitomo Chemical Company, Limited | Plant disease control composition and method of controlling plant disease |
WO2013086397A1 (en) * | 2011-12-08 | 2013-06-13 | Array Biopharma Inc. | Urea compounds as gka activators |
WO2015118793A1 (ja) | 2014-02-07 | 2015-08-13 | 住友化学株式会社 | (r)-1,1,3-トリメチル-4-アミノインダンの製造方法 |
WO2015141564A1 (ja) | 2014-03-18 | 2015-09-24 | 住友化学株式会社 | 光学活性な化合物の製造方法 |
JP2018039757A (ja) * | 2016-09-08 | 2018-03-15 | 日産化学工業株式会社 | イミダゾール誘導体の製造方法 |
-
2021
- 2021-07-06 US US18/005,161 patent/US20230257408A1/en active Pending
- 2021-07-06 KR KR1020237003992A patent/KR20230041010A/ko unknown
- 2021-07-06 IL IL299590A patent/IL299590A/en unknown
- 2021-07-06 CA CA3186051A patent/CA3186051A1/en active Pending
- 2021-07-06 WO PCT/JP2021/025489 patent/WO2022014414A1/ja active Application Filing
- 2021-07-06 AU AU2021308138A patent/AU2021308138A1/en active Pending
- 2021-07-06 CN CN202180049266.3A patent/CN115836041A/zh active Pending
- 2021-07-06 BR BR112022026601A patent/BR112022026601A2/pt unknown
- 2021-07-06 EP EP21842357.2A patent/EP4186882A1/en active Pending
- 2021-07-06 JP JP2022536280A patent/JPWO2022014414A1/ja active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07215921A (ja) | 1993-10-22 | 1995-08-15 | Shell Internatl Res Maatschappij Bv | 有害生物防除剤および中間体の製造方法 |
WO2011162397A1 (en) | 2010-06-24 | 2011-12-29 | Sumitomo Chemical Company, Limited | Plant disease control composition and method of controlling plant disease |
JP2012025735A (ja) * | 2010-06-24 | 2012-02-09 | Sumitomo Chemical Co Ltd | 植物病害防除組成物及び植物病害防除方法 |
WO2013086397A1 (en) * | 2011-12-08 | 2013-06-13 | Array Biopharma Inc. | Urea compounds as gka activators |
WO2015118793A1 (ja) | 2014-02-07 | 2015-08-13 | 住友化学株式会社 | (r)-1,1,3-トリメチル-4-アミノインダンの製造方法 |
WO2015141564A1 (ja) | 2014-03-18 | 2015-09-24 | 住友化学株式会社 | 光学活性な化合物の製造方法 |
JP2018039757A (ja) * | 2016-09-08 | 2018-03-15 | 日産化学工業株式会社 | イミダゾール誘導体の製造方法 |
Non-Patent Citations (7)
Title |
---|
ANGEW. CHEM. INT. ED., vol. 55, 2016, pages 10839 |
APPLIED CATALYSIS A: GENERAL, vol. 492, 2015, pages 252 - 261 |
GUO JUN, LU ZHAN: "Highly Chemo-, Regio-, and Stereoselective Cobalt-Catalyzed Markovnikov Hydrosilylation of Alkynes", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, ¬VERLAG CHEMIE| :, vol. 55, no. 36, 26 August 2016 (2016-08-26), pages 10835 - 10838, XP055899787, ISSN: 1433-7851, DOI: 10.1002/anie.201605501 * |
J. AMER. CHEM. SOC., vol. 134, 2012, pages 4561 - 4564 |
J. CHEM. SOC. (C, 1966, pages 514 |
TETRAHEDRON LETTERS, vol. 45, 2004, pages 8988 |
ZUO ZIQING, YANG JI, HUANG ZHENG: "Cobalt-Catalyzed Alkyne Hydrosilylation and Sequential Vinylsilane Hydroboration with Markovnikov Selectivity", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 55, no. 36, 26 August 2016 (2016-08-26), pages 10839 - 10843, XP055899789, ISSN: 1433-7851, DOI: 10.1002/anie.201605615 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114773263A (zh) * | 2022-05-16 | 2022-07-22 | 江苏百康德医药科技有限公司 | (r)-2,2,4-三甲基-1,2,3,4-四氢喹啉的制备方法 |
CN114773263B (zh) * | 2022-05-16 | 2023-09-05 | 江苏百康德医药科技有限公司 | (r)-2,2,4-三甲基-1,2,3,4-四氢喹啉的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20230041010A (ko) | 2023-03-23 |
CN115836041A (zh) | 2023-03-21 |
US20230257408A1 (en) | 2023-08-17 |
EP4186882A1 (en) | 2023-05-31 |
JPWO2022014414A1 (ja) | 2022-01-20 |
IL299590A (en) | 2023-03-01 |
BR112022026601A2 (pt) | 2023-01-24 |
AU2021308138A1 (en) | 2023-02-23 |
CA3186051A1 (en) | 2022-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6948419B2 (ja) | クロマノン誘導体の新規な製造方法 | |
WO2004099149A1 (ja) | 2-クロロ-5-フルオロ-3-置換ピリジンまたはその塩の製造方法 | |
WO2015118793A1 (ja) | (r)-1,1,3-トリメチル-4-アミノインダンの製造方法 | |
WO2022014414A1 (ja) | 光学活性な化合物の製造方法 | |
CN117550960A (zh) | 用于制备1-(3,5-二氯-4-氟-苯基)-2,2,2-三氟-乙酮的方法 | |
CN114901644A (zh) | 制备右美托咪定的方法 | |
CA2516465A1 (en) | Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds | |
WO2016133217A1 (ja) | 光学活性オキシインドール化合物の製造方法及びそれに触媒として用いられるトリアゾリウム塩 | |
JP4667593B2 (ja) | 2−アルキル−2−アダマンチル(メタ)アクリレート類の製造法 | |
JP5569938B2 (ja) | ピロリジン誘導体及びその製造方法 | |
JP4258658B2 (ja) | アセチレン化合物の製造方法 | |
WO2013011999A1 (ja) | 光学活性2-メチルプロリン誘導体の製造法 | |
JP2008115178A (ja) | ジフェニルアラニン−Ni(II)錯体の製造方法 | |
AU2007330711B2 (en) | Method for the synthesis of N-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2H-1,5-benzoxathiepin-3-amine | |
WO2022014413A1 (ja) | 光学活性な1,1,3-トリメチル-4-アミノインダンの製造方法 | |
WO2001060795A1 (fr) | Procedes pour preparer des derives d'aminoacides a activite optique | |
JP2010018531A (ja) | 3−ベンジルオキシベンゼンチオールの製造方法 | |
CN117616014A (zh) | 异恶唑啉羧酸衍生物的制备方法 | |
US7528276B2 (en) | Process for preparing the intermediate compounds for PPAR α ligands | |
JP4968602B2 (ja) | ベンズアミド誘導体の製造方法 | |
CN113185376A (zh) | 一种(z)-3-甲硫基-2-溴丙烯酸酯化合物的合成方法 | |
JP2000355592A (ja) | 3−メルカプト−1−(1,3−チアゾリン−2−イル)アゼチジンの製造法 | |
JP2004250340A (ja) | 4−ヒドラジノテトラヒドロピラン化合物又はその酸塩の製法 | |
JP2005194227A (ja) | 光学活性3,3,3−トリフルオロ−2−ヒドロキシプロピオン酸誘導体の製造方法 | |
CN106278968A (zh) | 一种合成硫代氨基酸衍生物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21842357 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 299590 Country of ref document: IL |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022026601 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2022536280 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3186051 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 112022026601 Country of ref document: BR Kind code of ref document: A2 Effective date: 20221226 |
|
ENP | Entry into the national phase |
Ref document number: 20237003992 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021308138 Country of ref document: AU Date of ref document: 20210706 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2021842357 Country of ref document: EP Effective date: 20230217 |